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Summary 
Wound healing within the oral mucosa demonstrates “foetal-like” responses 
with minimal scarring. This preferential healing has been attributed to the 
phenotypic characteristics of Oral Mucosa Fibroblasts (OMF), which display 
enhanced replicative potential. Adult stem cell populations discovered 
throughout the body including the oral cavity led to the discovery of a novel 
stem cell population within the lamina propria. 
This investigation aims to characterise this stem cell population in 
comparison with populations isolated from the lamina propria by different 
means, in an attempt to describe the preferential properties of a progenitor 
cell population within the tissue. Differential adhesion to fibronectin facilitated 
the isolation of clonally derived stem cell populations (clone x), a cell 
population representing the whole lamina propria, analogous to OMF (LO), 
and cells which do not adhere to fibronectin within the context of the 
differential adhesion assay (NA). 
Population doublings indicated that all cell populations were capable of 
exceeding the growth potential of BMSCs, however populations 
demonstrated distinct growth characteristics during the early phase of 
growth. All cell populations demonstrated an increase in cell size over time in 
culture, associated with replicative senescence. Active telomerase was 
detected in all cell populations; however this was not sufficient to prevent 
cellular senescence in any cell population, with telomere degradation 
apparent in many cell populations. 
xiii 
 
Differentiation was achieved in all cell populations, with temporal differences 
in gene expression observed during adipogenesis. The success of the 
theoretically progenitor depleted NA population to successfully undergo 
differentiation suggests that the current isolation method, clonal expansion 
after fibronectin adherence, may not be the most practical means by which to 
enrich for a stem cell population from the Lamina Propria of the Oral Mucosa. 
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CHAPTER 1 
INTRODUCTION 
  
2 
 
With recent advances in the field of stem cell research, the use of stem cells 
for therapeutic purposes has become the subject of much debate. 
 Embryonic stem (ES) cells derived from the inner cell mass of an embryo 
are capable of forming tissues from all embryonic germ layers, the 
endoderm, mesoderm and ectoderm (Fig. 1.1). With pluripotency and a 
limitless capacity for self-renewal in vitro, ES cells are the ideal choice for 
regenerative medicine. However, the use of ES cells and the manner in 
which they are obtained causes moral and ethical concerns for society and 
science alike.  
Adult stem cells (ASCs) are a solution to the ethical concerns over ES cells, 
as they are isolated without the destruction of an embryo, depending on 
tissue of origin can be easily isolated, and represent an autologous source 
for tissue repair circumventing any tissue rejection concerns involved in 
allogeneic treatments. One of the main issues involved with the isolation of 
adult stem cells for clinical applications is the size of the biopsy required to 
isolate an adequate number of stem cells; as the stem cells found in adult 
tissues make up such a small proportion of the cells present. The oral 
mucosa however, has long been known to heal rapidly with minimal to no-
scarring when compared to the skin, a tissue very similar in structure and 
function (Sloan et al., 1991, Stephens and Genever, 2007, Urmacher, 1990). 
This rapid healing has lead to the description of the oral mucosa as having a 
“foetal-like” phenotype (Irwin et al., 1994), and the hypothesis that a 
progenitor cell population plays a part in this effect. 
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Fig 1.1: The principle definition of stem cells; self-renewal through replication, and 
differentiation into multiple lineages of all germ layers. (Fortier, 2005). 
 
 
 
Embryonic stem cell (ES 
cell) 
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1.1 Developmental Origins of the Oral Mucosa 
The mesenchymal of the head and neck is primarily constituted of neural 
crest cells, originating from the ectodermal germ layer that forms the nervous 
system. This is also known as the ectomesenchyme or neuroectoderm and 
gives rise to all of the connective tissues of the face, including dental 
structures. (James K. Avery, 2002). The oral mucosa is derived from this 
ectomesenchyme from neural crest cells which migrate from the midbrain to 
the relevant brachial arches and intersperse within the mesenchymal tissue 
already present. Once there these cells proliferate extensively and provide a 
great contribution to the development of oral cavity cultures including the oral 
mucosa and teeth (Winning and Townsend, 2000). Development of the 
craniofacial structures involves crucial epithelial-mesenchymal interactions, 
and these interactions are subsequently important in the maintenance of oral 
mucosa (Mackenzie and Hill, 1984). At 5-6 weeks development, two layers of 
epithelial cells line the oral cavity, by 10 weeks the multilayered epithelium is 
present and by 23 weeks in utero, an oral epithelium with adult 
characteristics is present. 
 
1.2 Structure and Function of the Oral Mucosa 
The oral mucosa, like the skin, is a continuous layer which plays a crucial 
role in the maintenance of an organism through a number of processes. 
These include regulation of water and electrolyte balance, thermoregulation 
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and as a barrier against factors such as micro-organisms (Sloan et al., 1991, 
Stephens and Genever, 2007, Urmacher, 1990). 
Both tissues comprise a number of distinct layers; an epithelium principally 
composed of squamous stratified cells which vary in morphology from 
cuboidal at the basement membrane to flat squamous at the epithelial 
surface, an underlying layer of connective tissue cells containing dense 
vascular and neural networks, excretory and secretory glands and in the skin 
hair follicles, and a deeper layer of adipose tissue (Fig. 2 and Fig. 3) (Sloan 
et al., 1991, Stephens and Genever, 2007, Urmacher, 1990). 
 
1.2.1 The epithelium 
The epithelial layer in the oral mucosa (or epidermis in the skin) is composed 
principally of keratinocytes, which are named due to the production of 
filamentous keratins as the cells undergo terminal differentiation. Other cells 
are present in the epithelium of both the oral mucosa and the skin (Table 1). 
In the oral mucosa this layer can be keratinised (gingival, hard palate) or non-
keratinised (soft palate, under-side of tongue, alveolar mucosa, labial 
mucosa, and buccal mucosa) (Sloan et al., 1991). Keratinised epithelium 
comprises four layers; the stratum (S.) basale, S. spinosum, S. granulosum 
and the S. corneum. The similarities observed in the keratinised epithelia of 
both tissues are due to similarities in function, such as the ability to withstand 
shear stress and friction. This is due to the cornified outer layers of the 
epithelia (Stephens and Genever, 2007). Cell division occurs within the S. 
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basale whereupon the cells can remain in the basal layer or migrate towards 
the S. corneum and terminally differentiate into a squamous stratified cell 
(Fig. 3b). The differentiation state of keratinocytes within the epithelium can 
be determined by the expression of cytokeratins, which changes as cells 
migrate and form the S. corneum, a layer of anucleated cells containing 
keratins (Fuchs and Green, 1980). 
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Fig 1.2: A schematic representation of the oral mucosa, highlighting the similarities to the 
skin (Stephens and Genever, 2007). 
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Fig 1.3: Histology of oral mucosa and skin. Haematoxylin and Eosin staining demonstrating 
the structure of non-keratinised oral buccal mucosa (Fig 3a) and (b) skin (Fig 3b). Oral 
mucosa contains a thicker epithelial layer than the skin with distinct protrusions into the 
lamina propria, which is thinner than observed in the skin. Note the lack of a keratinised layer 
in the oral mucosa, clearly visible in the skin (Stephens and Genever 2007). 
Epithelial layer 
Lamina propria 
200 µm 
Epidermal layer 
200 µm 
a 
b 
Papillary dermis 
Reticular dermis 
Dermis 
Squamous stratified epithelium  
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Non-keratinised epithelium is structurally distinct from the epidermis in the 
skin and keratinised oral epithelia. It comprises three layers, the S. basale, S. 
intermedium and S. superficiale; lacking the cornified layer seen in the 
epidermis. It is less able to resist damage than keratinised epithelium. Keratin 
14 is expressed highly in the S basale, and keratin 19 is heterogeneously 
expressed in all layers in contrast to keratinised epithelium where this is only 
found in Merkel cells (Table 1.1) (Su et al., 1996). In organotypic culture 
buccal mucosal fibroblasts have exhibited production of keratins K5-8 and 
K13-17 (Hansson et al., 2003). As cells migrate from the basal layer into the 
intermediate and superficial layers, the cells become flattened and show an 
increase in keratin filaments. Membrane thickening is also observed, as well 
as an increase permeability to water compared to the epidermis (Lesch et al., 
1989). 
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Table 1.1: A table showing the cell types present in the oral and skin epithelia (Sloan et al., 
1991).  
Cell Type Characteristics Function 
Keratinocyte Population of rapidly renewing cells 
which undergo terminal differentiation 
and migration to the cornified layer 
Resistant to compressive and 
sheer forces and abrasion. 
Barrier to the elements and 
infection by micro-organisms 
Langerhans Cell Bone marrow derived dentritic cells in 
the supra-basal region, often close to 
the papillary tips. 
Immunity: presentation of 
antigens to regulatory T-
lymphocytes 
Granstein Cell Similar to Langerhans Cell Immunity: presentation of 
antigens to helper T-
lymphocytes 
Merkel Cell Neural cell located in the basal layer Epithelial sensory receptor 
Melanocyte Dendritic cell of neural crest origin 
forming a continuous network in the 
basal layer 
Synthesis and transfer of 
melanin to adjacent cells 
 
  
11 
 
The epithelial layer is penetrated by undulating connective tissue protrusions 
known as papillae or Rete‟s ridges, which provide a complex epithelial-
connective tissue junction with a large surface area for nutrition and 
attachment of the epithelia (Sloan et al., 1991).  
The epithelial-connective tissue junction is known as the lamina in the oral 
mucosa and the basement membrane in the skin. This layer can be 
subdivided into two regions, the lamina lucida and the lamina densa (basal 
lamina). The lamina lucida is composed of laminin and decreases in density 
towards the epithelium, while the lamina densa contains laminin and type IV 
collagen, and is connected to the lamina propria. Basal epithelial cells are 
attached to the lamina lucida. Anchoring fibrils of type VII collagen are 
responsible for cell attachment to the lamina on the connective tissue side 
(Stephens and Genever, 2007). Other matrix components, such as 
fibronectin, tenascin, and entactin are present in the basal complex. 
 
1.1.3 The lamina propria 
The lamina propria in the oral mucosa and the dermis in the skin is the tissue 
underlying the epithelium (Fig. 1.2, Fig. 1.3). This can be divided into two 
regions, the papillary and the reticular lamina propria. The papillary layer 
contains the vasculature and neural components which provide the epidermis 
with nutrition and sensory information. The extracellular matrix (ECM) of the 
papillary layer is composed of a heterogeneous mixture of predominantly 
type I collagen, with type III collagen, elastic fibres, glycosaminoglycans, 
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proteoglycans and glycoproteins. The reticular lamina propria is thicker than 
the papillary layer, but similar in composition, and extends to the 
submucosa/hypodermis (Stephens and Genever, 2007). 
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Table 1.2: A table showing the cell types present in the lamina propria (Sloan et al., 1991). 
Cell Type Characteristics Function 
Fibroblasts Heterogeneous cell population of 
spindle-like cells 
Synthesis and turnover of 
extracellular matrix and 
growth factors. Interactions 
with epithelium and heavily 
involved in wound healing 
Mast cells Large polygonal cells containing 
metachromatic granules 
Inflammatory and immune 
reactions. Interactions with 
blood vessels and the matrix 
Immune cells Macrophages, Lymphocytes etc… Defence, scavenging, 
immune reactions, including 
inflammation 
Vascular cells Endothelial cells, lining of vessels 
or formation of capillaries 
Nutrition, lymphatic drainage 
Peripheral nerve 
cells 
Schwann cells and specialised 
nerve endings 
Transmission of sensory 
information 
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The principle cell type of the lamina propria is the fibroblast (Table 1.2), 
which produces the majority of the ECM, and plays a pivotal role in wound 
healing. Fibroblasts repopulate an area of lost tissue in a wound site and 
rapidly produce new provisional ECM. They also bring about contraction of 
the wound and remodel the ECM to form a fibrotic scar. 
Although the ECM structure and composition is similar in both the lamina 
propria and the dermis, the non-keratinised oral mucosa shows differences 
related to function. Due to the requirement of a more flexible, recoiling tissue 
for mastication, speech and swallowing, the ECM is loose and has fewer, 
more slender papillae, with a higher elastic fibre composition. Also, the 
presence of other appendages varies with function; within the oral mucosa 
minor salivary and sebaceous glands interrupt the otherwise continuous 
structure; in the skin the salivary glands are absent, replaced by hair follicles. 
The submucosa and the hypodermis lay beneath the lamina propria and the 
dermis, respectively. They are arranged into lobules, separated by thin bands 
of dermal connective tissue that make up the interlobular space. Within these 
lobules reside mature adipocytes, and an extensive network of nerves, blood 
and lymphatic vessels. The function of this layer is as a mechanical cushion 
and insulation. The presence of submucosa is dependent on function; 
keratinised oral mucosa has very little whereas non-keratinised has a 
significantly sized submucosa (Stephens and Genever, 2007) 
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1.3 Wound Responses in the Oral Mucosa 
 
1.3.1 Wound Healing 
In higher vertebrate animals, damage to tissues by wounding leads to a loss 
of haemostasis, triggering a fibroproliferative response resulting in wound 
closure and scar formation. The oral mucosa and skin follow a near-identical 
model of wound healing; this process can be divided into three well defined, 
overlapping stages; inflammation, proliferation and ECM formation and 
remodelling (Clark, 1996).  
 
1.3.1.1 Haemostasis 
Tissue injury causes microvascular injury and extravasation of blood into the 
wound space. Within minutes this stimulates platelet aggregation and 
activation of extrinsic and intrinsic coagulation cascades, ultimately 
facilitating the formation of a fibrin clot and prevention of further blood loss. 
This restores tissue haemostasis (Fig. 1.4). Platelet aggregation leads to the 
release of Hageman factor XII, which triggers the intrinsic pathway for 
coagulation through the conversion of a series of proenzymes to their active 
forms (Li et al., 2007). The extrinsic pathway is activated by the release of a 
lipoprotein named tissue factor from damaged tissues. This tissue factor is 
also present on the surface of activated monocytes and endothelial cells, 
which participate in the coagulation reactions. Platelets are also responsible 
for the release of other growth factors and cytokines which mediate the 
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recruitment of immune cells and tissue remodelling, such as transforming 
growth factors α and β (TGF-α/β) and platelet-derived growth factor (PDGF). 
 
1.3.1.2 The inflammatory phase 
After this restoration of haemostasis, the inflammatory phase sees the 
recruitment of monocytes and neutrophils from capillaries which migrate into 
the wounded tissue. In early inflammation (<12 hours) neutrophils are the 
predominant cell type, giving way to macrophages in late inflammation (>12 
hours) (Li et al., 2007). Macrophages and neutrophils are recruited by the 
release of chemotactic factors released during haemostasis as well as mast 
cells, which secrete tumour necrosis factor (TNF), histamine, proteases and 
cytokines. Neutrophils destroy any bacteria which may have invaded the 
wound, as well as damaged matrix proteins. In late inflammation the 
macrophage is pivotal in the movement to the proliferative phase of wound 
healing, being responsible for the removal of any remaining pathogens, 
debris and neutrophils (Li et al., 2007, Clark, 1996). 
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Fig 1.4. The main phases of wound healing, adapted from (Clark, 1996) 
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 1.3.1.3 The proliferative phase 
The proliferative phase involves the migration of cells into the wound space and the 
generation of granulation tissues and a new epithelium. 
 
1.3.1.3.1 Re-epithelialisation 
Re-epithelialisation begins with the migration of keratinocytes from the free 
edges of the wound within 24 hours. The keratinocytes at the wound edge 
lose the strong cell-cell and cell-matrix interactions found in normal tissue. 
Keratinocytes interact with the fibronectin rich provisional matrix formed 
during the clotting process; the migratory direction is regulated by the binding 
of integrin receptors to newly formed collagen in the wound bed (Li et al., 
2007). The keratinocytes migrate by lamellipodial walking, moving in a “leap-
frog” fashion. These migratory cells lack the associated keratins and filaggrin 
normally seen in terminally differentiated keratinocytes, yet remain 
phenotypically distinct from keratinocytes residing in the basal layer of the 
epidermis (Stephens and Thomas, 2002). Growth factors and matrix 
metalloproteinases (MMPs) have also been implicated, MMP-9 being 
involved in the degradation of type IV collagen and laminin, enabling 
detachment from the basement membrane and migration into the wound site. 
The formation of a new basement membrane completes the re-
epithelialisation process. 
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1.3.1.3.2 Generation of ECM 
Fibroblasts migrate into the wound space within 3-4 days of injury, using the 
provisional matrix as a substrate, and begin to provide scaffolding and 
contact guidance for cells to migrate and form granulation tissue. This 
process is known as fibroplasia. Fibroblasts proliferate in the wound space, 
producing a collagen rich matrix 2-7 days after injury (Li et al., 2007). This 
matrix is composed of collagen I and III, and contains fibronectin (Kurkinen et 
al., 1980). Angiogenesis also occurs, with the degradation of local basement 
membrane by endothelial cells, sprouting of new vasculature into the fibrin 
clot, reconstruction of basement membrane and maturation of the blood 
vessel. 
 
1.3.1.4 Wound contraction 
The final phase of wound healing involves wound contraction and the 
remodelling of the ECM produced by fibroblasts during the proliferative 
phase. The fibronectin produced in the formation of granulation tissue 
diminishes over time as the matrix is remodelled (Kurkinen et al., 1980) This 
process involves the induction of MMPs 1-3, enzymes which are each 
involved in the catabolism of different ECM components. These enzymes are 
controlled by natural tissue inhibitors of matrix metalloproteinases (TIMPS), 
and the balance between MMP and TIMP expression is crucial to normal 
matrix remodelling. 
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During wound contraction phenotypic changes to the fibroblasts populating 
the wound occur, with a switch to a pro-fibrotic myofibroblast phenotype, 
characterised by an increase in expression of α-smooth muscle actin. The 
attachment of these cells to each other and the surrounding matrix then 
facilitates wound contraction, with the myofibroblasts contracting 
pseudopodia attached to the ECM. This remodelling of the ECM in the skin 
leads to scar formation. However, the outcome observed in the oral mucosa 
has some marked differences, which may be due to intrinsic characteristics 
of the tissue (Szpaderska et al., 2003). 
 
1.3.2 Differences in healing in the oral mucosa and the skin 
Great differences have been observed in wound healing between the oral 
mucosa and the skin. Oral mucosa wound repair is characterised by rapid re-
epithelialisation as well as enhanced wound repopulation and matrix 
reorganisation in vitro. Oral mucosal wounds were shown to contain 
significantly lower levels of macrophages, neutrophils and T-cells when 
compared with dermal wounds (Shannon et al., 2006, Szpaderska et al., 
2003). Oral mucosal fibroblasts (OMFs) were shown to produce increased 
levels of epithelial mitogens keratinocyte growth factor (KGF) and hepatocyte 
growth factor (HGF), produce lower levels of α-smooth muscle actin, all 
factors implicated in fibrotic wound healing (Shannon et al., 2006, Stephens 
et al., 2001b). OMFs have also been shown to exhibit greater proliferation in 
the presence of basic fibroblast growth factor (bFGF) in vitro (Lee and Eun, 
1999). It has been shown that OMFs exhibit an increased ability to remodel 
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ECM and contract a wound by use of fibroblast populated collagen lattices 
(Stephens et al., 1996, Lee and Eun, 1999, Okazaki et al., 2002). The matrix 
metalloproteinase activity of OMFs has also been shown to be superior to 
dermal fibroblasts, with increased levels of MMP-2 with a decreased 
production/activation of TIMPs (Stephens et al., 2001a). More recently, 
research had demonstrated that oral fibroblasts are phenotypically distinct, 
and are capable of achieving a higher number of cumulative population 
doublings in vitro when compared to patient matched skin fibroblasts (Enoch 
et al., 2010, Enoch et al., 2009), and it was hypothesised that the wound 
healing characteristics may be due to the presence of a progenitor/stem cell 
population within the lamina propria of the oral mucosa (Stephens and 
Genever, 2007). 
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1.4 Embryonic Stem Cells 
Stem cells can be classified broadly into two groups, embryonic and adult. 
Embryonic stem (ES) cells are totipotent cells derived from the inner cell 
mass of a blastocyst, and are able to differentiate into cell lineages derived 
from the ectoderm, mesoderm and endoderm (Keller, 1995). ES cells have 
rapid growth rates, with cell division occurring every 36-48 hours, and can be 
cultured for prolonged lengths of time, up to 2 years (Fortier, 2005). This 
requires the correct conditions; either exogenous growth factors must be 
added to the culture media or the ES cells must be cultured on a feeder cell 
population to supply the necessary growth factors (Lee et al., 2005). ES cells 
have high levels of telomerase expression, which allows sustained renewal 
without compromising the chromosomal stability. 
 
1.4.1 Embryonic Stem Cell Discovery 
Embryonic stem cells were first isolated from early mouse embryos after the 
discovery that injection of these early embryos into histocompatible mice 
caused the formation of teratocarcinomas in the host (Stevens, 1970). These 
cells were discovered to have morphological and immunological properties in 
common with pluripotent embryonic cells, which had been studied 
extensively to understand embryonic development. In the 1980‟s the 
establishment of stable cell cultures from mouse embryos allowed 
investigation into all the mechanisms involved in embryonic differentiation 
and capacity for self renewal by the use of mitotically inactive embryonic 
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fibroblasts, known as “feeder cells” (Notarianni et al., 1990, Robertson et al., 
1986, Kaufman et al., 1983, Evans and Kaufman, 1981).  It was discovered 
that even after extended propagation in vitro, cells were still able to re-enter 
embryogenesis when injected into pre-implantation mouse embryos, giving 
rise to chimaeric mice (Bradley et al., 1984). Importantly, ESCs maintain a 
diploid karyotype, important in a cell capable of unrestricted self renewal.  
Embryonic stem cells are described as totipotent, due to their ability to give 
rise to many cell types including germ cells however they cannot produce 
trophoectoderm due to the nature of ES cells, derived from the developing 
blastocyst (Smith, 2001). ES cells can be routinely expanded whilst 
remaining undifferentiated and large populations of cells (109-1010) can be 
generated rapidly. However this required the necessary nutrients provided 
from a feeder cell population until the discovery that a single cytokine, LIF 
could sustain mouse ES cell self-renewal in the absence of feeder cells 
(Smith et al., 1988, Williams et al., 1988). Other factors were subsequently 
discovered to be essential for pluripotency, such as Oct-3/4 (Niwa, 2001).  
 
1.4.2 Differentiation Potential of Human ES Cells 
As previously mentioned, ES cells are isolated from the blastocyst of 
developing embryos, and as well as those discovered in mice, have also 
been characterised in humans (Thomson et al., 1998). The differentiation of 
ES cells typically allows the formation of free floating “embryonic bodies” in 
culture before a variety of differentiated cells are detected. In this manner 
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neurons, skeletal muscle and cardiomyocytes, liver and islet cells, capable of 
producing insulin, have been reported among many other cell types (Assady 
et al., 2001, Kaufman et al., 2001, Kehat et al., 2001, Itskovitz-Eldor et al., 
2000, Odorico et al., 2001). 
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1.5 Adult Stem Cell Populations 
Adult stem cells can be found in tissues of ectodermal, mesodermal and 
endodermal origin. These adult stem cells can be separated into two broad 
groups; the hematopoietic (HSC) and mesenchymal stem cells (MSC). HSCs 
are of mesodermal origin, and produce the cell types of the hematolymphatic 
system. More recently it has been observed that they can generate cell types 
from outside of this lineage (Fortier, 2005, Bellantuono, 2004). 
 
1.5.1 Bone Marrow Stromal Cells 
Mesenchymal stem cells (MSCs), also known as bone marrow stromal cells 
(BMSCs) or mesenchymal progenitor cells (MPCs) are derived from the 
mesoderm, and are the progenitors of all connective tissue cells such as fat, 
bone, tendon, muscle and cartilage. These cells have a fibroblastic 
morphology in culture and are capable of differentiating into multiple cell 
types, including those mentioned above. MSCs were first isolated from the 
bone marrow 40 years ago and where originally referred to as colony forming 
unit fibroblasts (Castro-Malaspina et al., 1984, Castro-Malaspina et al., 1982, 
Castro-Malaspina et al., 1980, Friedenstein et al., 1970). BMSCs represent 
an interesting target for cellular therapies due to their proliferation and 
differentiation characteristics (Johnstone et al., 1998). Bone marrow is a 
complex tissue comprising haematopoietic stem cells and their progeny and 
a connective tissue network, the stroma (Bruder et al., 1997). This stroma is 
comprised of adipocytes, reticulocytes, endothelial cells and fibroblastic cells, 
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and it has been noted that the adherent cells derived from bone marrow 
cultures are composed of different cell populations. The heterogeneous 
nature of BMSC cultures has led to the discovery that individual samples 
from within a culture of BMSCs can exhibit dramatically different expression 
of genes by microarray analysis (Xiao et al., 2010). 
Single cell colonies of BMSC have been demonstrated to achieve 50 
population doublings and are capable of differentiation into osteoblasts, 
adipocytes, chondrocytes, myocytes, astrocytes, oligodendrocytes and 
neurons (Kuznetsov et al., 1997b, Kuznetsov et al., 1997a, Aslan et al., 2006, 
Bosnakovski et al., 2004, Bosnakovski et al., 2006, Deliloglu-Gurhan et al., 
2006, in 't Anker et al., 2003, Johnstone et al., 1998, Jones et al., 2002, 
Lecanda et al., 1997, Long et al., 1995, Majumdar et al., 2000, Mareddy et 
al., 2007) (Friedenstein et al., 1970, Bruder et al., 1997). This clonal culture 
system allows for the characterisation of a marrow stromal cell population in 
more detail. It has been determined that basic fibroblast growth factor (FGF-
2) is a potent mitogen implicated in the maintenance of BMSC proliferation 
and osteogenic potential, able to extend the replicative potential of cultured 
cells to more than 70 population doublings (Yanada et al., 2006, Martin et al., 
1997, Xiao et al., 2010). 
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1.5.2 Haematopoietic Stem Cells 
 Experiments on mice in 1940 showed that shielding the spleen during total 
body irradiation allowed the animal to survive previously lethal doses of 
radiation (Jansen et al., 2005).  The discovery that haemopoietic stem cells 
(HSC‟s) were responsible for the animals‟ recovery then followed.  HSC‟s are 
the progenitor cells of all lymphoid and myeloid cells within the blood and 
originate from the bone marrow (Janeway C.A, 2001).  They have been 
categorised by the presence of CD34 on their surface, however this marker is 
not exclusive to stem cells and is also present on some mature lymphoid 
cells (Watt and Contreras, 2005).  CD34 is a ligand for Leukocyte Adhesion 
Molecules (LAM) and helps with the adhesion of leukocytes to the 
endothelium. Shortly after HSC‟s discovery various research groups began 
working on the safe collection of these cells so they could be infused into 
patients undergoing chemo- and radiotherapy as a treatment.   
Un-stimulated peripheral blood contains fewer HSC‟s naturally than in an 
equivalent volume of bone marrow (Jansen, J. et al, 2005) but the use of 
granulocyte colony stimulating factor (G-CSF) as a HSC liberating factor has 
increased stem cell yield so it is possible for PBSC‟s to be used in HSCT‟s 
(Basak et al., 2011, Grigg et al., 1995). 
 
1.5.3 Adipose Derived Stem Cells 
Human adipose tissue has been identified as a source of adult stem cells 
similar in phenotype and differentiation potential to BMSC, with some 
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differential expression of cell surface markers implicated in haematopoietic 
stem cell mobilisation (Zuk et al., 2002, Gabbay et al., 2006, Gimble and 
Guilak, 2003a, Gimble and Guilak, 2003b, Katz et al., 2005, Kern et al., 2006, 
Lee et al., 2004, De Ugarte et al., 2003). These cells are a heterogeneous 
population similar to BMSCs and successful clonal expansion from single 
progenitor cells has demonstrated differentiation along the standard lineages, 
including neurogenic differentiation (Guilak et al., 2006). It has also been 
observed that adipose derived stem cells are capable of forming insulin 
producing cells (Kim et al., 2010). The ease of access to obtain adipose-
derived stem cells, from lipoaspirates, has generated interest in these cells 
as an alternative to BMSC for tissue regeneration and repair. 
 
1.5.4 Skin Stem Cells 
Within the skin, a tissue structurally and functionally similar to the oral 
mucosa, a number of stem cell populations have been identified, residing in 
discrete compartments of the tissue.  
 
1.5.4.1 Epidermal Stem Cells 
The epidermis, which is a highly proliferative layer of constant turnover has 
been shown to contain a stem cell population responsible for this high rate of 
self renewal (Jones and Watt, 1993). Recently it has been discerned that 
these epidermal stem cells can trans-differentiate into corneal epithelium-like 
cells (Gao et al., 2007).  
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1.5.4.2 Hair Follicle Stem Cells 
The hair follicle has been shown to contain a stem cell population capable of 
differentiating into adipogenic and osteogenic lineages in vitro (Jahoda et al., 
2003, Gharzi et al., 2003). More recently, evidence that these cells are 
capable of neuronal and glial potential has been demonstrated (Hunt et al., 
2008). 
 
1.5.4.3 Dermal Multipotent Stem Cells 
Skin derived precursors (SKP‟s), cells isolated from the dermis of juvenile and adult 
rodents have been shown to differentiate into neurons, glia, smooth muscle cells 
and adipocytes (Toma et al., 2001, Fernandes et al., 2004). These cells were also 
identified in the human dermis of neonatal foreskin. These human SKPs have been 
maintained for long periods of time in culture, and are able to differentiate into 
neurons, glia, and smooth muscle cells, including cells with the phenotype of 
peripheral neurons and Schwann cells (Toma et al., 2005). More recently, these 
SKPs have been differentiated into functional melanocytes (Li et al., 2010). Dermal 
multipotent cells have also been shown to speed up skin wound healing and 
haematopoietic recovery in sub-lethally irradiated rats (Chunmeng et al., 2004) 
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1.5.6 Other Adult Stem cell populations 
A number of other adult stem cell populations have been identified to date, in 
a variety of tissues and sites throughout the body. The renal papilla has been 
postulated to contain a kidney stem cell niche capable of deriving cells 
expressing neuronal markers and cells of uncharacterised phenotype (Oliver 
et al., 2004). Articular cartilage also contains a progenitor cell population 
capable of mesenchymal differentiation in vitro (Alsalameh et al., 2004, 
Dowthwaite et al., 2004, Fickert et al., 2004, Hiraoka et al., 2006, Williams et 
al., 2010).  
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1.6 Stem Cell Isolation Methods 
The isolation of stem cells from adult tissues has lead to a number of 
techniques for the isolation of stem cells from the heterogeneous cell 
populations in which they reside. 
 
1.6.1 Differential Adherence Properties 
The adherence characteristics of stem cell populations can be exploited to 
isolate them from a heterogeneous cell population. In the case of muscle 
derived stem cells and blood derived MSC, this can be through their 
preferential adherence to tissue culture plastic (Sinanan et al., 2004, Wagner 
et al., 2005) or through differential adherence to extracellular matrix 
components such as collagen or fibronectin (Jones and Watt, 1993, 
Dowthwaite et al., 2004). The differential adhesion characteristic of stem cells 
allows for clonogenic expansion of single cells giving rise to a pure cell 
population, and in terms of fibronectin adherence can be explained by high 
levels of functional α5β1 integrin, the „classical‟ fibronectin receptor 
(DeSimone et al., 1992) 
 
1.6.2 Magnetic Separation/Fluorescence Activated Cell Sorting (FACS) 
Markers present on the surface of stem cell populations can also be used to 
isolate these cells from a heterogeneous environment through magnetic 
separation, or through the detection of fluorescence conjugated antibodies to 
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markers of interest. Cardiac stem cells have been isolated using magnetic 
separation, staining with an anti stem cell antigen (sca-1) antibody 
conjugated to a magnetic microparticle allows for the enrichment of this cell 
population when cells are passed through a magnetic field (Oh et al., 2003). 
Similarly FACS has been used in Dental Pulp stem cells to isolate small cell 
populations using STRO-1  (Shi and Gronthos, 2003). 
 
1.6.3 Hoechst Exclusion 
Another method of isolating stem/progenitor cell populations involved the use 
of a fluorescent dye, Hoechst 33342 which is excluded by stem cells and 
provides a means of identification during FACS. This characteristic is due to 
the expression of ABCG2, a membrane transporter capable of rapid 
exclusion of the dye and resulting in a population with no fluorescence 
(Honda et al., 2007, Tsai et al., 2010). 
  
As well as the isolation methods demonstrated above to physically acquire 
stem cell populations; a lot of research has been conducted into the 
phenotypic characteristics which differentiate stem cells from differentiated 
cells. 
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1.7 Stem Cell Characteristics used in Identification of Stem 
Cell Populations from Adult Tissues 
 
1.7.1 Telomerase Activity and Replicative Senescence 
In humans, individual cells can only undergo a predefined number of 
divisions. This phenomenon is seen in most somatic cells, and is referred to 
as Hayflick‟s limit (Hayflick, 1965). If cells are allowed to undergo unlimited 
replication, then over time mutations accumulated through erroneous DNA 
replication would cause damage to vital genetic information and could lead to 
carcinogenesis, by the inactivation of cell cycle checkpoints such as p21, and 
tumour suppressor genes, such as retinoblastoma (Rb) or p53. Limiting the 
number of population doublings a cell can achieve is a method of protecting 
against the development of cancer. 
When cells have reached this defined number of population doublings they 
enter cell cycle arrest, and no longer divide. This is known as senescence, 
and a number of mechanisms can cause this (Fig 1.5). Replicative, or 
telomere-dependent senescence is caused by the dysregulation or 
shortening of telomeres, and will be the focus of this section 
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1.7.1.1 Telomeres 
Telomeres are regions of repetitive, non-coding double stranded DNA found 
at the end of eukaryotic chromosomes. Human telomeres consist of 6 base-
pair repeats of the sequence 5‟- TTAGGG -3‟, with a 3‟ single stranded DNA 
overhang. Human telomeres are generally about 10,000 nucleotides in 
length, and capped with double-stranded and single-stranded DNA binding 
proteins. The overhanging strand of DNA folds back into the double stranded 
region of the telomere, forming a “T-loop” (Watson, 2003). This loop structure 
is designed to prevent the recognition of the telomere as a chromosomal 
break, which triggers cellular repair mechanisms involved in the maintenance 
of chromosomal integrity. Telomeres help to slow the end replication problem 
encountered during DNA synthesis (Shay and Wright, 2007).  
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Fig 1.5: The end replication problem. Lagging strand synthesis involves the use of primers in 
a discontinuous manner, which poses a problem when the end of the lagging strand is 
reached (Brown, 2002). . 
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DNA polymerase only synthesises new DNA in a 5‟ to 3‟ orientation. This 
means that on the lagging strand of DNA synthesis occurs discontinuously, 
using RNA primers to facilitate the function of DNA polymerases (Fig.1.5). 
When the replication reaches the end of this lagging strand, an RNA primer 
cannot be inserted at the tip of the DNA molecule, meaning that with every 
replication a portion of genetic information is lost. Telomeres lose between 
50-100 base-pairs with every cell division, and this loss acts as a record of 
the number of times a cell has undergone division (Alberts, 2002). When the 
telomere becomes too short then the cell cycle is arrested, to prevent the 
loss of critical genetic information contained in genes found near the ends of 
the chromosome, such as tumour suppressor genes of cell checkpoint 
genes. Loss of these genes can lead to a number of pathological processes 
such as cancers.  
There are many diseases in which telomere shortening has been implicated 
(Wiemann et al., 2002, Plentz et al., 2004, Meeker et al., 2004, Benetos et 
al., 2004, Brouilette et al., 2003). In most human somatic cells, this 
degradation of telomeric DNA over numerous replications triggers replicative 
senescence. In highly proliferative somatic cells and germ line cells however, 
telomere lengths are maintained by a specialised reverse transcriptase 
known as telomerase (Wright et al., 1996). 
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1.7.1.2 Telomerase 
The reverse transcriptase enzyme known as telomerase is responsible for 
the maintenance of telomere length, and is highly conserved in all eukaryotes 
(Autexier and Lue, 2006). It has been shown that in normal human 
fibroblasts, the reconstitution of telomerase activity by retroviral transfection 
can extend their replicative potential and extend the length of the telomeres 
(Vaziri and Benchimol, 1998) Telomerase is composed of two subunits, a 
catalytic subunit known as human telomerase reverse transcriptase (hTERT) 
in humans (Nakamura et al., 1997) and an RNA template known as 
telomerase RNA component (TERC) (Feng et al., 1995). 
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Fig 1.6: A schematic representing the elongation of telomeric DNA by the enzymatic activity 
of telomerase.  (Image taken from http://accessscience.com/content/Cell-senescence-and-
aging/YB000230) 
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The TERC subunit component contains 1.5 copies of the complement to the 
telomere sequence (5‟-UAACCCUAA-3‟), which anneals to the single 
stranded DNA at the 3‟ end of the telomere (Fig 1.6a) (Alberts, 2002). As well 
as this the telomerase binds to the DNA substrate and then the TERT 
reverse transcriptase activity sequentially adds new nucleotides to the DNA 
substrate until the end of the RNA template is reached (Fig 1.6b). At this 
point telomerase detaches and translocates and re-anneals to the end of the 
telomere and repeats the reverse transcription reaction (Fig  1.6d). This 
cycle is repeated a variable number of times, and leads to multiple copies of 
the 6 base-pair repeat being added to the DNA, and the maintenance of 
telomere length. 
 
1.7.1.3 Telomerase in Stem Cells  
Telomerase activity in ES is well characterised. It is involved in embryonic 
development and has been detected in cells of the inner cell mass of human 
blastocysts (Heins et al., 2004, Thomson et al., 1998). Embryonic stem cells 
and Embryonal Carcinoma cells demonstrate high levels of telomerase 
activity and hTERT expression, and during differentiation these are rapidly 
downregulated, suggesting that telomerase activity is a marker of 
undifferentiated stem cells (Armstrong et al., 2005).  
The subject of adult stem cells and telomerase activity is at present unclear, 
with reports of telomerase activity in adult stem cells reported by groups 
being contradicted by the findings of others. Haematopoietic stem cells are 
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shown to possess telomerase activity (Hiyama et al., 1995, Morrison et al., 
1996, Chiu et al., 1996). This activity is retained in some of the differentiated 
progeny. However, no telomerase activity has yet been found in MSCs from 
adult tissues and this lack of telomerase potential is believed to contribute to 
the limited replicative potential of MSC (Fehrer and Lepperdinger, 2005, 
Zimmermann et al., 2003). However, the addition of bFGF has been 
demonstrated to increase the replicative potential of MSC to over 100 
population doublings, without the upregulation of telomerase (Yanada et al., 
2006). Telomerase activity has been observed in human neural precursor 
cells, hepatic stem cells and cardiac stem cells (Ostenfeld et al., 2000, 
Schmelzer and Reid, 2009). 
 
1.7.2 Cell Surface Marker Expression 
In the process of isolating stem cells from adult tissues, a vast array of 
techniques are employed, and many groups have chosen to use flow 
cytometry to characterise these stem cells by examining  a series of both cell 
surface and intracellular markers. This has led to a comprehensive list of 
markers which have been used as confirmation of mesenchymal stem cells 
within the subject tissue, which is summarised in table 1.3. 
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Table 1.3: Cell surface markers used in previous studies to identify stem cell populations 
residing within a variety of tissues 
Tissue of origin Positive markers Negative markers Reference 
Periodontal Ligament CD105, CD166, STRO-1 N/A (Nagatomo et al., 
2006) 
Human trabecular 
bone 
STRO-1, CD73, CD105 CD34, CD45, 
CD144 
(Song et al., 2005, 
Tuli et al., 2003) 
Osteoarthritic 
Cartilage 
CD9, CD44, CD54, 
CD90, CD166 
N/A (Fickert et al., 2003) 
Bone marrow CD44, CD90, CD105, 
CD166, HLA-ABC 
CD45, AC133 and 
HLA-DR 
(Pasquinelli et al., 
2007) 
Osteoarthritic bone 
marrow 
CD29, CD44, CD90, 
CD105, CD166 
N/A (Mareddy et al., 
2007) 
Adipose CD34, CD90, CD105 
CD166 
CD31, CD45 (Oedayrajsingh-
Varma et al., 2006) 
Dental papilla CD29, CD44, CD90, 
CD105, CD166 
N/A (Ikeda et al., 2006) 
Bronchi CD73, CD90, CD105, 
CD166, STRO-1 
CD34, CD45 (Sabatini et al., 
2005) 
Articular cartilage CD10, CD90, CD105, 
CD166 
N/A (Diaz-Romero et al., 
2005) 
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1.7.2.1 Markers used for current stem cell identification 
For the purpose of this investigation, the three markers CD90, CD105 and CD166 
were chosen because of the frequency with which these markers appear in research 
into stem cells in other tissues, the intensity with which they are expressed and the 
wide ranging tissue in which they have been used for the identification of stem cells. 
 
1.7.2.2 Structure and Function of selected cell surface markers 
 
1.7.2.2.1 CD90: Thy-1 
Thy-1, otherwise known as CD90, is a 25-37 kDa glycosylphosphoinositol 
(GPI)-anchored protein found on the external leaflet of the lipid bilayer. The 
gene for this protein is located on chromosome 11q22.3, and is expressed on 
human fibroblasts, neurons, blood stem cells and endothelial cells (Rege and 
Hagood, 2006a). Thy-1 has associations with the formation of focal 
adhesions, via modulation of p190 Rho GTPase-activating proteins, which 
results in RhoA activation (Barker et al., 2004). Thy-1 is also implicated in 
wound healing and fibrosis, with upregulation seen 3-6 days after injury 
(Saalbach et al., 1996). Interactions with a number of integrins has also been 
observed in endothelial cells  and neurons (Rege and Hagood, 2006b). Thy-1 
can act as both a receptor and a ligand dependent on the cell interactions 
involved. 
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1.7.2.2.2 CD105: Endoglin 
CD105 is a disulphide-linked homodimeric cell membrane glycoprotein of 
180kDa, which can exist as one of two isoforms, L and S (Gougos and 
Letarte, 1988). The gene for CD105 is located on chromosome 9q34, and 
arranged into 14 exons (Fernandez-Ruiz et al., 1993, McAllister et al., 1995). 
The L-CD105 variant is found predominantly on the surface of endothelial 
cells. Endoglin has been shown to be a receptor involved in transforming 
growth factor (TGF) β signalling, binding to TGF-β1 and TGFβ-3 with a high 
affinity resulting in down-regulation of phosphorylation, similar to the effect 
seen in the presence of protein kinase C inhibitors (Cheifetz et al., 1992, 
Lastres et al., 1994). Endoglin also has associations with angiogenesis with 
respect to tumour metastasis in a wide range of tumour endothelia (Duff et 
al., 2003). Evidence of the crucial involvement of Endoglin in angiogenesis 
can be seen in knockout mice, which have numerous cardiac and vascular 
defects (Li et al., 1999). It also binds growth factors such as bone 
morphogenetic proteins (BMPs) (Duff et al., 2003).  
 
1.7.2.2.3 CD166: Activated leukocyte cell adhesion molecule 
Activated leukocyte cell adhesion molecule (ALCAM) is a type I 
transmembrane protein and a member of the immunoglobulin superfamily 
(IgSF). It is a cell adhesion molecule comprised of five extracellular Ig 
domains, a single transmembrane domain and a short cytoplasmic tail 
(Masedunskas et al., 2006, Arai et al., 2002). First identified in Thymic cells 
and activated leukocytes it also displays significant sequence similarity to a 
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subset of the IgSF involved in neural adhesion (Bowen et al., 2000, Arai et 
al., 2002). ALCAM is a ligand of CD6, a scavenger receptor cysteine-rich 
(SRCR) protein belonging to the SRCR protein superfamily (Resnick et al., 
1994). It is involved in the transendothelial migration of monocytes. ALCAM 
has also been implicated in invasion of endothelial cells into cartilage (Arai et 
al., 2002), as well as the implantation of blastocysts, neurite outgrowth and 
the invasion of melanoma cells. 
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1.8 Stem Cells from the Oral Cavity 
Stem cells, as mentioned previously, have been isolated from a number of 
adult tissues. For the purpose of this thesis, this section will focus on the 
presence of stem cell populations in oral tissues. 
1.8.1 Dental Pulp Stem Cells 
Upon injury, reparative dentin is formed as a protective barrier for the pulp, 
suggesting that the dental pulp contains a population of progenitors to aid in 
this healing response (Mao et al., 2006). A stem cell population has been 
demonstrated in the dental pulp of impacted third molars from humans aged 
from 19-29 years of age (Gronthos et al., 2000). These cells were 
phenotypically similar to BMSCs with a higher colony forming efficiency, but 
exhibited a reduced capability for osteogenic differentiation in vitro, and a 
lack of adipogenic potential. When transplanted into immunocompromised 
mice, these cells were capable of forming a dentin like structure lined with 
human odontoblasts-like cells, and these cells surrounded a pulp-like tissue. 
In other experiments, the transplantation of dental pulp stem cells into 
immunocompromised mice demonstrated the ability to form bone (Otaki et 
al., 2007b). Since that initial discovery much work has been conducted to 
elucidate the full differentiation potential, with groups demonstrating 
successful adipogenesis and the generation of neural-like cells (Gronthos et 
al., 2002, Arthur et al., 2008). Dental Pulp Stem Cells (DPSCs) have now 
been isolated from permanent and deciduous teeth (Suchanek et al., 2007), 
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and culture conditions have been optimised for increased proliferative activity 
using additional supplements and low serum concentrations (Karbanova et 
al., 2010, Suchanek et al., 2009). An epithelial stem-cell like cell population 
has recently been discovered, within human deciduous dental pulp which 
may play a role as an epithelial component of repair and regeneration in 
teeth (Nam and Lee, 2009). Investigations into telomere erosion suggest that 
similar to MSCs, DPSCs do not express active telomerase (Mokry et al., 
2010).  
1.8.2 Periodontal Ligament Stem Cells 
The periodontal ligament (PDL) connects the cementum to alveolar bone, 
and functions primarily to support the tooth in the alveolar socket (Mao et al., 
2006). 
Several groups have reported the isolation of multipotent periodontal 
ligament stem cells (PDLSCs). The expression of STRO-1 has been used to 
select for these stem cells, with evidence that these stem cells are 
comparable to BMSCs in terms of their differentiation potential along the 
common lineages (Gay et al., 2007). These cells have been successfully 
isolated from cryopreserved periodontal ligament. The preserved cells 
retained the ability to generate cementum/periodontal ligament tissues, as 
well as single cell colony generation and adipogenic, chondrogenic and 
osteogenic differentiation ability (Seo et al., 2004). The presence of 
embryonic pluripotency markers Oct-4, Nanog, SSEA-1 and SSEA-4 have 
suggested that PDLSCs are less differentiated than BMSCs. 
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1.8.3 Oral Keratinocyte Stem Cells 
Within the Oral mucosa, a stem cell population has been identified and 
characterised. Using the expression of α6β4 integrin and CD71 by magnetic 
separation, three cell populations were isolated from keratinized oral mucosa, 
and the α6β4positive CD71negative population where demonstrated to express 
Oct-4 and CD44 and where able to reconstitute an epithelial equivalent in 
vitro (Calenic et al., 2010). Another group used the high expression of p75 to 
isolate keratinocyte stem cells, whilst the presence of β1 integrin was used to 
characterise sorted oral keratinocytes by another group (Izumi et al., 2007, 
Nakamura et al., 2007). 
 
1.8.4 Hard Palate Stem Cells 
A stem cell population has been successfully isolated from adult palatum of 
Wistar rats. These cells were positive for Klf-4, Oct 4 and c-Myc, factors 
involved in the pluripotency of stem cells (Widera et al., 2009). 
 
1.8.5 Oral Mucosa Lamina Propria Stem Cells 
Within the context of oral stem cells, and of particular interest to this thesis is 
the recent discovery of multipotent stem cell populations within the lamina 
propria of the oral mucosa. These cells have been demonstrated to achieve 
higher numbers of population doublings compared to mesenchymal stem 
cells and other adult stem cell populations, are phenotypically similar in terms 
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of cell surface marker expression, and capable of differentiation along 
adipogenic, osteogenic, chondrogenic and neural lineages (Davies et al., 
2010, Marynka-Kalmani et al., 2010). These cells express neural crest 
markers, as well as three of the four markers required for induced 
pluripotency (Nakagawa et al., 2008, Takahashi et al., 2007a, Takahashi et 
al., 2007b, Takahashi and Yamanaka, 2006). 
 
1.8 Ethical Considerations of Embryonic Stem Cell Research 
Whilst the potential of embryonic stem cells is clear, the ethical implications 
of use therapeutically remain restrictive to their clinical use, due to the nature 
of ESC isolation. This involves the destruction of an embryo, and in the case 
of human ES cells, this is deemed by many as an insurmountable problem. 
Adult stem cell populations are seen as an alternative that do not violate any 
ethical concerns, however limitation in replicative potential and lineage 
capability are still restricting the full potential of these cells for therapeutic 
benefit. The isolation of a pluripotent stem cell population with the benefits of 
embryonic stem cells would be of great scientific and therapeutic interest and 
would settle the debate over the use of embryonic stem cells for clinical uses. 
 
1.9 Aims of this thesis 
The overall aim of this thesis was to compare cell populations from the 
lamina propria of the oral mucosa, isolated by different means, in an attempt 
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to describe the preferential properties of a progenitor cell population within 
this tissue.  In so doing the aim was to study these distinct cell populations 
with respect to their growth kinetics and cellular morphology throughout their 
proliferative lifespan until they reached senescence and thereby assess any 
cell-specific age related changes.  Furthermore, to determine the expression 
of well known stem cell markers such as CD90, CD105, CD166 and active 
telomerase within these cell populations and relate this to in vitro ageing 
through a potential link to telomere length. Finally, to compare the potential of 
these populations to differentiate down classical cell lineages, namely 
undergo osteogenesis, chondrogenesis and adipogenesis.  
   
It was hypothesized that:  
 Clonally derived oral mucosal lamina propria cells, isolated by 
adherence to fibronectin, would exhibit a distinct cell phenotype when 
compared to whole cell populations (LO) or the residual cells that had 
not adhered to fibronectin (NA). 
 The oral mucosal lamina propria clones would demonstrate 
stem/progenitor cell characteristics. 
 Clonal populations would demonstrate a more stem/progenitor cell-like 
phenotype compared to the more heterogeneous LO and NA cell 
populations, as exhibited by their stem cell markers and superior 
differentiation capability in vitro. 
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CHAPTER 2 
MATERIALS AND METHODS 
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2.1 Cell Culture 
All cell culture described in this thesis was carried out in sterile working 
conditions within an Astec Microflow 2 Cabinet. All flasks and plates were 
maintained within a Nuaire air-jacketed DH autoflow automatic CO2 incubator 
at 37°C at 5% CO2. All reagents used were purchased from Invitrogen, UK 
unless otherwise stated in the protocol 
 
2.1.1 Isolation of cells from the lamina propria of the oral 
mucosa 
Buccal mucosa tissue samples were collected from consenting patients 
undergoing routine dental procedures. Samples were sterilised by immersion 
in 70% ethanol for 40 seconds then dissected into 3mm long cubes and 
digested in culture media [Dulbecco‟s Modified Eagle‟s Medium (DMEM) 
supplemented with 10% Foetal Calf Serum (FCS), 2mM Glutamine, 
antibiotics and antimycotics [(100 units ml-1 Penicillin G, 100μg ml-1 
Streptomycin sulphate, 0.25μg ml-1 Amphotericin B)] containing 2mg ml-1 
Pronase (Sigma®, UK) overnight at 4°C. Subsequent to pronase digestion 
the epithelium was removed using forceps, and the lamina propria minced 
and incubated in culture media containing 1mg ml-1 collagenase A (Sigma®, 
UK).  
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2.1.2 Isolation of progenitor cells from the oral mucosa using 
the differential adhesion assay  
Progenitor cells were isolated from the lamina propria using the differential 
adhesion assay (Dowthwaite et al., 2004, Jones and Watt, 1993). The 
differential adhesion assay is based on the principle that progenitor cells 
express a higher level of functional β1 integrin receptors on their surface, 
which will allow adherence to fibronectin in a reduced timeframe compared to 
differentiated cells (Jones and Watt, 1993).  
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Fig 2.1 Schematic of the differential adhesion assay highlight the point in the protocol at 
which each cell population is isolated. 
 
40 min 
Well 1 Well 3 
Isolated progenitor 
cells 
Well 2 
CHARACTERISATION 
Isolated 
Clones 
10-12 days 
Non-adherent 
Population 
Mixed 
Population 
40 min Digested lamina 
propria seeded onto 
fibronectin coated 
plates 
Fibronectin 
20 min 
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Six-well plates were coated with 10μg ml-1 bovine fibronectin (FN; Sigma, 
UK) in phosphate buffered saline (PBS pH 7.4) containing 1mM MgCl2 and 
1mM CaCl2 (PBS+) overnight at 4°C. Control plates were treated with PBS+ 
containing 1% bovine serum albumin (BSA; Sigma®, UK). FN and BSA were 
aspirated before the addition of the cells, and the protocol was followed as 
demonstrated in Fig 2.1. 
Isolated cell suspensions were adjusted to 8x104 cells ml-1 in serum free 
media [DMEM media supplemented with 2mM glutamine and 
antibiotics/antimycotics (100 units ml-1 Penicillin G, 100μg ml-1 Streptomycin 
sulphate, 0.25μg ml-1 Amphotericin B)] seeded into a well and incubated at 
37°C for 20 minutes (well 1) (Fig. 8). Media (and unattached cells) were 
removed and seeded into the next well for 40 minutes at 37°C (well 2). This 
was repeated and unattached cells were added to the final well for a further 
40 minutes (well 3). Unattached cells removed after this final time point were 
centrifuged at 1500 RPM [Precision Durafuge 200, Roche, France] for 5 
minutes. The pellet was resuspended in 1ml of culture media and the cells 
counted. These cells [from this point will be termed as the non-adherent 
population] were then seeded into the well of a separate uncoated 6-well 
plate and a further 1ml culture media added. After removal from 20 minute 
and both 40 minute time points (n=3), media was replaced with 2ml of culture 
media. 
The remaining cells not used in the assay were also centrifuged (as above) 
and seeded into a well of a separate uncoated 6 well plate and termed the 
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“mixed” population, which reflects both the progenitor and fibroblast 
populations resident within the lamina propria. 
 
2.1.3 Colony forming efficiency 
To evaluate the colony forming efficiency (CFE) of this progenitor cell 
population, the initial number of adherent cells was counted in all 3 wells after 
24 hours. On days 5, 9 and 14 the number of colonies visible exceeding both 
4 cells and 32 cells were individually recorded. The CFEs were calculated 
using the formula: 
CFE = No. of colonies formed 
No. of adherent cells 
2.1.4 Isolation of colonies 
At day 14 individual colonies in excess of 32 cells originating from a single 
cell were isolated and removed from well 1 using trypsin [0.25% with EDTA] 
digestion. Media was aspirated from the plates and the cells washed with 
sterile PBS. After removing the PBS, cloning rings were placed over the 
colonies selected for study. Trypsin (200μl) was added to the cloning ring, 
incubated for 5 minutes at 37°C and removed and placed into a falcon 
centrifuge tube with an equal volume of culture media. Then culture media 
was added to cloning ring to remove any cells which had not been removed 
previously. The cell suspension was then centrifuged at 1500 RPM for 5 
minutes. The supernatant was then aspirated and the pellet resuspended 
and seeded into a well of a 12 well plate and grown until confluent, and 
56 
 
passaged until senescence. At every passage cell numbers were recorded 
for both seeding and splitting of flasks to determine population doublings. 
 
2.1.5 Cryopreservation and retrieval of cells 
Cryopreservation was conducted at every passage to ensure adequate 
stocks were available for subsequent experiments. For cryopreservation, 
cells were resuspended in a solution of 10% (v/v) dimethyl sulfoxide (DMSO 
– Sigma®, UK), and 90% FBS. This cell suspension was placed into 
cryogenic vials (Greiner,UK) and stored at -80°C in an isopropanol 
cryopreservation container. After 24 hours cells were retrieved from this 
container and placed into long term liquid nitrogen storage. Frozen cells were 
retrieved from storage by rapid thawing at 37°C, washed in DMEM+10% FBS 
and following centrifugation (1500 RPM, 5 minutes) were resuspended in 
DMEM+10% FBS for cell counting. 
 
2.1.6 Calculation of Population Doubling Levels 
To allow comparisons between cell populations in terms of cellular 
proliferation, cumulative population doublings were plotted against time in 
culture. At every passage cells were counted, using Trypan blue exclusion to 
determine the number of viable cells, on a Neubauer haemocytometer 
(Sigma®, UK). The number of cells reseeded into a fresh flask was also 
recorded. Population doublings were then calculated using the formula 
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PDL = [log10(total cell number at passage)-log10(reseeded cell count)]/log10(2) 
 
Cells were considered to be senescent when their population doublings/week 
fell below 0.5 for three consecutive passages, at which point cells were 
cryopreserved awaiting subsequent analysis. 
 
2.1.7 Routine testing for Mycoplasma contamination of cell 
cultures 
Cell lines were routinely screened for presence of Mycoplasma 
contamination, every 2-4 passages. Cells were cultured overnight  at 1x104 
cells per well  in a 6 well plate containing 25mmx25mm coverslips, then 
washed with 1mL of PBS. Hoechst 33258 stain (bizbenzimide; Aventis, 
Germany) was applied to the coverslips at 1μg/ml in methanol (Sigma®, UK), 
and incubated for 15 minutes. After this time, the coverslips were removed 
from the plate wells using forceps, dabbed on tissue to ensure excess 
moisture was removed, and mounted on microscope slides for fluorescence 
imaging. Images were acquired on an Olympus PROVIS AX470 (TRF) 
Microscope using a Nikon DXM1200 Digital Camera and Nikon ACT-1 
software. The images were reviewed in Adobe Photoshop Elements. 
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2.1.8 Morphological Analysis 
Images of cells were taken at every passage, 24 hours after seeding (x10 
and x20 magnification, F3.5, Nikon Coolpix 4500 Camera). Images taken at 
x10 magnification were then subjected to morphology analysis using the Java 
based software ImageJ (Version 1.37, obtained from the National Institutes of 
Health website http://rsb.info.nih.gov/ij/, USA. Programmer: Wayne 
Rasband). The scale was set using a haemocytometer image at x10 
magnification, and cell area was traced and recorded (n=50). Average cell 
areas were then plotted for early and late passages. These timepoints were 
determined by the individual cell population, with early passages 
representing around 10 population doublings, and late timepoints determined 
by the total population doublings of each individual cell population. 
 
2.2 Stem Cell Phenotypic Analysis by Flow 
Cytometry 
2.2.1 Flow Cytometric analysis of stem cell associated cell 
surface marker 
The cell surface markers, CD90, CD105 and CD166 were selected from the 
literature as a positive marker triplicate for mesenchymal stem cells. The 
antibodies CD34 and CD45 were also used as negative controls for the 
exclusion of haematopoietic and fibrocytic cell lineages. Isotype controls for 
each antibody were also used as negative controls. 
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Table 2.1: Antibodies raised against the CD markers CD34, CD45, CD90, 105 and 166 and 
corresponding isotype controls used in the flow Cytometric analysis of isolated clone. All 
antibodies were uses at a 1:50 dilution for staining of 5x10
5
 cells. 
Antibody Conjugate Supplier 
CD90 Allophycocyanin (APC) RnD Systems 
IgG2A Allophycocyanin (APC) RnD Systems 
CD105 Phycoerythrin (PE) Ancell 
IgG1 Phycoerythrin (PE) Ancell 
CD166 Fluorescein Isothiocyanate (FITC) Ancell 
IgG1 Fluorescein Isothiocyanate (FITC) Ancell 
CD34  Fluorescein Isothiocyanate (FITC) Ancell 
CD45 Phycoerythrin (PE) Ancell  
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Table 2.2. Showing the key for the labelling of cell samples with respective antibodies 
Tube Number Antibody added 
1 Anti-CD90, APC Conjugated 
2  
3 Anti-CD105, PE Conjugated 
4 IgG1, PE Conjugated 
5 Anti-CD166, FITC Conjugated 
6 IgG1, FITC Conjugated 
7 Anti-CD90, Anti-CD105, Anti-CD166 triplicate 
8 Anti-CD34 FITC Conjugated 
9 Anti-CD45 PE Conjugated 
10 Anti CD-90, Anti-CD34, Anti CD45 triplicate 
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After trypsinisation of flasks, half a million cells were added to each of 7 
numbered microcentrifuge tubes, which were then centrifuged (Eppendorf 
Centrifuge 5415R, Eppendorf, UK) for 5 minutes at 2000 revolutions per 
minute (RPM) at 4°C and the supernatant aspirated. The antibodies (Table 
2.1) were diluted 1:50 in PBS and added to the relevant tube (Table 2.2). The 
cells were incubated with the antibody for 45 minutes at 4°C, and then 
centrifuged at 2000 RPM for 5 minutes at 4°C. After aspirating the 
supernatant the pellets were washed in 1ml PBS and centrifuged again as 
above. This was repeated, and after aspiration of the supernatant the cells 
were fixed in 100μl 2% fridge-cold paraformaldehyde (Sigma®, UK) for 2 
minutes on ice, and then centrifuged at 2000 RPM for 5 minutes at 4°C. The 
cells were then resuspended in 1ml PBS ready for analysis on the 
FACSCanto™ flow cytometer (Becton Dickinson, USA). Data was then 
analysed using Flowjo 7.2.1 (Treestar Inc, USA) 
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2.3 Quantification of active telomerase in cell 
lysates using the quantitative telomeric repeat 
amplification protocol (QTRAP) 
The presence of active telomerase was investigated using a quantitative real 
time polymerase chain reaction assay which exploits the telomeric extension 
property of telomerase. 
 
2.3.1 Extraction of active telomerase from cell pellets 
After trypsinisation, pellets of 5x105 cells were resuspended in PBS and 
transferred to a 1.5ml microcentrifuge tube for centrifugation at 15,000xg for 
2 minutes at 4°C. The supernatant was removed and the pellet resuspended 
in TRAPEZE CHAPS lysis buffer (Millipore, UK). The amount of lysis buffer is 
proportional to the cell count, added at a quantity of 1μl per 5x103 cells. Cells 
were then incubated on ice for 30 minutes before centrifuging at 20,000xg 
(Sigma® 3k15, Sigma®, UK) for 30 minutes at 4°C. The supernatants 
containing telomerase were snap-frozen in 10μl aliquots using dry ice. 
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2.3.2 Quantification of telomerase activity in frozen cell 
lysates  
 
Table 2.3 Primer Sequences for QTRAP Protocol 
TS Primer 5‟-AATCCGTCGAGCAGAGTT-3‟ 
ACX Primer 5‟-GCGCGGCTTACCCTTACCCTTACCCTAACC-3‟ 
 
For each sample assayed, reactions were made in triplicate. A mastermix 
was created calculated from the number of wells required plus additional 
wells to account for pipetting error (n+3). The mastermix comprised (per 
RXN) 12.5μl Sybr Green PCR Mix (Applied Biosystems, UK) 1μl Primer Mix 
(100ng TS primer and 50ng ACX Primer per μl [Table 2.3]) and 6.5μl sterile 
H2O giving a reaction volume of 20μl. Added to the wells of a 96 well clear 
plate (Abgene, UK) was 5μl of 1:5 diluted cell lysate. This gave a final 
reaction volume of 25μl per well. 
To generate a standard curve of telomerase activity, lysates from the 
telomerase positive cell line 501mel were used. These standards 
represented 10,000, 1,000, 100, 10, 1 and 0.1 cell/μl lysates, and were 
prediluted prior to the beginning of the assay. Test lysates were used at a 
concentration of 10,000 cells/μl lysates, which was demonstrated to be the 
best concentration for this assay. As a negative control, heat inactivated cell 
lysates were also plated. These were achieved by pre-incubation of cell 
lysates at 95°C for 10 minutes, during which time the telomerase enzyme 
becomes denatured and telomeric extension fails to occur.  
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Plates were then sealed with Absolute™ QPCR seals, and run on the ABI 
PRISM 7000 (Applied Biosystems, Foster City, USA) with the following 
cycling parameters: 
 
1. 25°C, 25 minutes 
2. 95°C, 10 minutes 
 
Followed by 40 cycles of: 
 
1. 95°C, 15 seconds 
2. 60°C, 90 seconds 
. 
Melting curve analysis was conducted for all reactions at 60°C. 
 
2.3.3 Analysis of Telomerase Activity 
Telomerase activity was quantified using the standard curve method. ABI 
PRISM 7000 SDS Software version 1.1 was used to determine the standard 
curve for the 501mel positive control. This curve was used to determine the 
relative telomerase activity of each sample as a percentage of the cell 
number matched 501mel lysate (10,000 cells).  
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2.4 Quantification of telomere length using the 
terminal restriction fragment (TRF) assay 
 
2.4.1 Extraction of genomic DNA 
At passaging, cells from early, mid and late time points in their replicative 
lifespan were pelleted in a 1.5mL RNase/DNase free microcentrifuge tube 
(Starlab, UK), at 5x105 cells per tube. Cells were washed in PBS to remove 
any residual media. Samples were kept on ice and resuspended in 300μl 
lysis buffer [200mM Tris-HCl pH7.5, 250mM EDTA, 0.5% Sodium Dodecyl 
Sulphate (SDS) in sterile H2O). To this was added 3μl ribonuclease A 
(RNase A, Sigma®, UK), and 6μl proteinase K (Sigma®, UK) and the 
solution was incubated overnight at 45°C. The next morning 300μl of phenol: 
choloroform:isoamyl:alcohol (25:24:1, Sigma®, UK) was added to each tube 
and the tubes mixed well by inversion periodically over 30 minutes at room 
temperature. The solution was subsequently centrifuged at 13000 RPM for 
five minutes, and the upper aqueous layer transferred to a fresh tube. DNA 
was precipitated using 300μl Sodium Acetate (3M, pH5.2, Sigma®, UK) and 
900μl ice-cold 100% ethanol for 20 minutes at -20°C. DNA was centrifuged at 
13000 RPM for 2 minutes, the supernatant decanted and the pellet washed 
in 500μl ice cold 70% ethanol and centrifuged for 2 minutes at 13000 RPM. 
The supernatant was decanted and the pellet air dried at room temperature 
for 2 hours. The DNA was then resuspended in 20μl RNase/DNase free 
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water and stored at -20°C until required. DNA Quantification was conducted 
using the Nanovue spectrophotometer (GE Healthcare, UK) using the DNA 
quantification program. 
 
2.4.2 Digestion of Genomic DNA 
Genomic DNA was digested according to the TeloTAGGG telomere length 
assay manufacturer‟s instructions (Roche, France). All reagents, unless 
otherwise stated, are available from Roche. 
 
2.4.2.1 Agarose Gel Electrophoresis of genomic DNA. 
For each sample to be tested, 1μg of genomic DNA was added to 1:5 
dilutions of 5X loading buffer (Promega, UK) in a total volume of 20μl in a 
0.2mL microcentrifuge tube. In addition, a tube containing 4μl DIG molecular 
weight marker 12μl nuclease-free water and 4μl of loading buffer was pulsed 
on a centrifuge along with the tubes containing genomic DNA, to ensure all 
liquid was deposited in the bottom of the tube. These samples were loaded 
onto a 0.8% Agarose gel in 1X TAE buffer with markers at each end of the 
gel, and one marker lane in the middle to ensure accurate measurements. 
The gel was then run at 100V for 2h in 1X TAE buffer until the bromophenol 
blue band had travelled at least 10cm from the loading wells. 
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2.4.2.2 Southern Blotting of Agarose Gel 
The Agarose gel was submerged in 0.25M Hydrochloric Acid (HCl, Sigma 
Aldrich, UK) solution subjected to gentle agitation for 5–10 min at room 
temperature until the bromophenol blue stain changes color to yellow. The 
gel was then washed twice with H2O and submerged in denaturing solution 
twice for 15 minutes at room temperature. The gel was then washed twice 
with H2O before being submerged in neutralisation solution twice for 15 
minutes at room temperature. The gel was then placed into a tray large 
enough to hold 20X SSC solution at a level lower than the Agarose gel being 
blotted (use of an internal mount to raise the gel above the liquid level 
achieved this). Onto the mount was placed 3mm filter paper, so that the filter 
paper ends were in contact with the 20X SSC solution. The Agarose gel was 
inverted and place upon the filter paper, and onto the gel was place a nylon 
membrane (Roche, UK). On top of this were placed four pieces of filter paper 
pre soaked in 2X SSC buffer. At this stage the tray and all of the contents 
were sealed with Saran wrap, and a weight placed over the tray to ensure 
compression of all the layers. This was left at room temperature for 6 hours, 
to ensure the DNA blotted to the nylon membrane by capillary action. After 
the southern transfer, the DNA was cross linked to the membrane using UV-
crosslinking (120mJ). 
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2.4.2.3 Hybridisation and Chemiluminescence Detection of Telomere 
length 
Prewarming of 25 ml of DIG Easy Hyb (Solution 7, Roche, France) was 
conducted to bring it to 42°C. The blotted membrane was submerged in 18ml 
of DIG Easy Hyb solution and incubated at 42°C with gentle agitation for 60 
minutes. Meanwhile the hybridisation solution was prepared by adding 1μl 
telomere probe per 5mL fresh prewarmed DIG Easy Hyb solution with 
thorough mixing. At least 6.5mL of this solution is required per 200cm2 
blotting membrane. After 60 minutes the prehybridisation solution was 
removed and the hybridisation solution containing the telomere probe was 
immediately added and the membrane incubated for 3 hours at 42°C with 
gentle agitation. After 3 hours the hybridisation solution was discarded and 
the membrane washed twice with stringent wash buffer for 5 minutes at room 
temperature, with gentle agitation. The membrane was then washed twice 
with stringent wash buffer II in a heater water bath, for 15-20 minutes at 
50°C. The membrane was then rinsed in at least 100mL 1X washing buffer 
for 5 minutes at room temperature with gentle agitation. The membrane was 
then washed in 1X blocking solution for 30 minutes at room temperature. 
Meanwhile, the Anti-DIG-AP working solution was prepared as per the 
manufacturer‟s instructions. After 30 minutes the membrane was washed 
twice with 1X washing buffer for 15 minutes at room temperature, before 
incubation with 100ml of 1X detection buffer for 5 minutes at room 
temperature with gentle agitation. After 5 minutes the buffer was discarded 
and the residual liquid removed by placing the membrane DNA side up on a 
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sheet of absorbent paper, however it was important not to let the membrane 
dry. The membrane was then placed in a hybridisation bag, DNA side facing 
upward and 40 drops (approximately 3mL) substrate solution was added to 
the membrane, with careful attention paid to the hetereogeneous distribution 
of the substrate buffer throughout the membrane. After sealing the edges of 
the hybridisation bag, the membrane was developed on the Typhoon Imager 
(GE Healthcare, UK). 
 
2.4.2.4 Analysis of Telomere Length 
The telomere lengths of individual samples were determined by calculating 
the median telomere length. Measurements were taken at the top and bottom 
of the visible bands of DNA, and the median calculated. This gives a 
numerical representation of telomere length within experimental samples, to 
allow comparisons between individual samples. 
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2.5 Adipogenic Differentiation 
To investigate the lineage potential of isolated cell populations, cells were 
induced along the adipogenic lineage by supplementation of culture media 
for 28 days using a previously established differentiation cocktail (Choi et al., 
2006). RNA was extracted at 7 day intervals until 28 days, and 28 day 
cultures were kept for histochemical staining for lipid deposition using Oil 
Red-O staining. 
 
2.5.1 Adipogenic induction of cell cultures 
Cells were seeded in 6 well cultures dishes (Greiner, UK) at 3x103 cells/cm2. 
Cells were cultured in DMEM+10%FBS until confluency. At this point the 
media was replaced with adipogenic induction media (DMEM+10%FBS 
supplemented with 10μg/ml insulin, 1μM dexamethasone, 100μM 
indomethacin, 100μM 3-isobutyl-1-methyl-xanthine [IBMX] (All Sigma, UK). 
Cells were also culture in standard DMEM+10% FBS media as a 
differentiation control. In total, enough cultures for RNA extractions in 
triplicate at day 7, 14, 21 and 28 for both adipogenic and control cultures 
were used. In addition, cells were seeded into three 8-well chamberslides 
(BD Falcon, UK) for adipogenic induction and three for control cultures for Oil 
Red-O staining. 
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2.5.2 Quantitative Real-Time (PCR QRT-PCR) detection of 
adipogenic mRNA from adipogenic cell cultures 
 
2.5.2.1 RNA Extractions of Adipogenic Cultures 
Differentiation cultures were stimulated for the required number of days (7-28 
days at 7 day intervals). Wells were washed with 1mL PBS and 1mL TRIzol 
(Invitrogen, UK) added for 5 minutes at room temperature. The wells were 
then transferred to 1.5mL microcentrifuge tubes (Starlab, UK) and 175μl 
Chloroform was added (Sigma®, UK), and the samples mixed well through 
gentle pipetting. The chloroform/TRIzol mix was transferred to a 1.5mL heavy 
phase lock tube (Fisher Scientific, UK) and centrifuged for 2 minutes at 
13000xg. The upper aqueous layer was transferred to an RNase free 1.5mL 
microcentrifuge tube and the RNA was precipitated by adding 500μl 
Isopropanol (Sigma®, UK), and placing at -20°C overnight. The resulting 
precipitate was centrifuged for 10 minutes at 12000xg at 4°C using an 
Eppendorf Bench top Durafuge (Eppendorf, Germany). The supernatant was 
removed; the pellet washed with 75% Ethanol and the centrifuged for a 
further 5 minutes at 7500xg. The supernatant was removed and the pellet air 
dried, then resuspended in 50μL sterile water. RNA concentration was 
quantified using the Nanovue spectrophotometer (GE Healthcare, UK). 
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2.5.2.2 cDNA Generation 
For the QRT-PCR, cDNA was generated from the total RNA isolated in 
section 2.5.2.1. For each reaction 1μg of total RNA was added to 0.5μg 
random hexamer primers (Promega, UK) in an RNase free 0.2ml 
microcentrifuge tube, with 13μl of sterile water. Reactions were incubated at 
70°C for 5 minutes followed by 5 minutes on ice. To each reaction 1μl 
RNasin, 5μl MMLV 5X Buffer, 5μl dNTPs (dCTP, dGTP, dATP, dTTP) and 
1μl MMLV Reverse Transcriptase were added (All Promega, UK). After 
thorough mixing, reactions were incubated for 10 minutes at 25°C, 60 
minutes at 42°C and 5 minutes at 95°C. The resulting cDNA was stored at -
80°C until required. 
 
2.5.2.3 QRT-PCR detection of lineage associated markers 
2.5.2.3.1 Primer Sequences 
Primer sequences were designed using Primer3, a web based software for 
the generation of primer sequences with strict parameters (i.e. %GC content, 
Ta/Tm, http://frodo.wi.mit.edu/primer3/input.htm). Primers were designed to 
span exon-exon boundaries, to ensure amplification of mRNA generated 
cDNA only, not genomic DNA. Parameters were set for 50% GC content and 
Ta 0f 60°C to ensure that all primers could be used under the same 
conditions on the ABI PRISM 7000 lightcycler. Sequences for the primers 
were as follows: 
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β-Actin (Forward) 5‟-AGGGCAGTGATCTCCTTCTGCATCCT-3‟ 
β-Actin (Reverse) 5‟- CACACTGTGCCCATCTACGAGGGGT -3‟  
Product Length – 500 base pairs (bp) 
LPL (Forward) 5‟- CCTGCTCGTGCTGACTCTGG-3‟ 
LPL (Reverse) 5‟-CATCCTGTCCCACCAGTTTGG-3‟ 
Product Length – 389bp 
PPARγ (Forward) 5‟- CCACAGGCCGAGAAGGAG AA-3‟ 
PPARγ (Reverse) 5‟- CTGGCAGCCCTGAAAGATGC-3‟ 
Product length – 302bp 
C/EBPα (Forward) 5‟- CCTTGTGCAATGTGAATGTGC-3‟ 
C/EBPα (Reverse) 5‟- CGGAGAGTCTCATTTTGGCAA-3‟ 
Product Length – 150bp 
 
2.5.2.3.2 Reference Control  
To ensure the accuracy of comparisons between plates, a reference control 
was used. Stratagene QPCR Human Reference Total RNA (Stratagene, 
USA) was purchased at a concentration of 1μg/mL. cDNA controls were 
generated for the generation of standards at using 5μg RNA per reaction, 
giving 100μl of 200ng/μl total cDNA. This was used to generate standards 
curves for each of the PCR primer pairs. 
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2.5.2.3.3 Reference Gene 
To ensure the differences in gene expression observed within the QRT-PCR 
reactions were a function of the biological processes involved, the used of β-
actin as a reference gene was employed. This allowed the generation of 
normalized expression of all other genes of interest back to the expression of 
the housekeeping gene β-actin 
 
2.5.2.3.4 QRT-PCR 
Reactions were conducted in 96 well clear PCR plates (Abgene, UK). A 
standard curve of the reference control cDNA was generated representing 
100ng, 10ng, 1ng, 0.1ng and 0.01ng cDNA to allow for comparisons between 
plates. Reactions were setup in triplicate for each sample with all timepoints 
on one plate, and the clonal populations on a plate together, and the NA/LO 
populations on another plate. Reactions were in a 25μl volume, comprising 
12.5μl SybrGreen PCR mix (Applied Biosystems), 1μl of 10μM primer mix 
and 6.5μl water. Into the wells of the 96 well plate, 100ng of sample cDNA 
was diluted into 5μl in triplicate, and the 20μl reaction mix was added to the 
5μl sample cDNA prior to running on the ABI PRISM 7000 (Applied 
Biosystems). Reactions were run under the following conditions: 2 minutes 
50°C, 2 minutes 95°C followed by 50 cycles of 15 seconds 95°C, 60 seconds 
60°C. Melting curve analysis was conducted at 60°C. 
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2.5.2.3.5 Analysis of Gene Expression 
Gene expression was quantified using the standard curve method. ABI 
PRISM 7000 SDS Software version 1.1 was used to determine the standard 
curve for the reference control cDNA. This curve was used to determine the 
relative expression of the target gene, and normalisation to β-actin 
expression accounted for any plate to plate or well to well variation. 
 
2.5.3 Histological investigation of adipogenic differentiation 
using Oil red-O staining 
After 28 days in either differentiation media or control media, chamber slides 
were washed with PBS and cells fixed with 70% ice cold ethanol for 15 
minutes at -20°C. Cells were washed again with 60% (v/v) Isopropanol 
(Sigma®, UK), for 5 minutes at room temperature before staining of cells with 
Oil Red-O (0.25% (w/v) Oil Red-O (Sigma®,UK) in Isopropanol) at room 
temperature with gentle agitation. Cells were rinsed with 60% isopropanol 
before washing with water. Chamberslide culture chambers were removed to 
reveal the underlying microscope slide, which was then in turn mounted with 
DPX (Sigma®,UK) and a coverslip was placed over the slide. After the DPX 
mount was dry, images were acquired using an Olympus PROVIS AX470 
(TRF) Microscope using a Nikon DXM1200 Digital Camera and Nikon ACT-1 
software. The images were reviewed in Adobe Photoshop Elements. 
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2.6 Chondrogenic Differentiation 
To investigate the lineage potential of isolated cell populations, cells were 
induced along the chondrogenic lineage by supplementation of culture media 
for 28 days in a pellet culture system using an established differentiation 
cocktail (Lee et al., 2004). After 28 days, pellets were kindly paraffin 
embedded and 10μm sections cut on a microtome by School of Dentistry 
Pathology MLSO Kath Allsop.  
 
2.6.1 Chondrogenic induction of cell cultures using the pellet 
culture system 
Cell pellets were generated using in 1.5mL sterile microcentrifuge tubes 
(Starlab, UK). Briefly, 5xx105 cells were centrifuges at 1500 RPM in 1mL of 
DMEM+10%FBS. Pellets were allowed to form overnight. DMEM+10%FBS 
was replaced with chondrogenic induction media (DMEM+10%FBS 
supplemented with 1x insulin, transferrin and selenium (ITS) supplement 
(Invitrogen, UK), 50μg/ml L-ascorbate (Sigma, UK) and 5ng/ml transforming 
growth factor beta 1 (TGF-β1) (Peprotech EC Ltd., UK)). Control pellets were 
incubated in the DMEM+10%FBS media alone. Media was change every two 
days, with care taken not to disrupt the pellet at the bottom of the tube, and 
after every media change pellets were centrifuged at 1500 RPM for 5 
minutes and replaced back into the incubator. 
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2.6.2 Evaluation of chondrogenic differentiation using 
general histology 
As mentioned in section 2.6, sections were kindly paraffin embedded and 
10μm sections cut on a microtome by School of Dentistry Pathology MLSO 
Kath Allsop. 
2.6.2.1 Haemotoxylin and Eosin (H&E) staining 
Sections were washed in Xylene (Fisher Scientific, UK) twice for 2 minutes, 
followed by 2 minute washes in decreasing alcohol concentrations (100%, 
90%, 75%). Cells were then washed in running tap water for 2 minutes, 
submerged in Mayer‟s Haemotoxylin for 2 minutes and washed in running 
water until the sections appear blue. Slides were then submerged in 1% 
Eosin solution for 2 minutes before washing in running water for 20 seconds. 
Sections were then dehydrated through increasing concentrations of alcohol 
as previously described, until two final 2 minute washes with Xylene. 
Sections were then mounted in DPX mounting medium (Sigma, UK) and 
coverslips placed on top, before images were acquired using an Olympus 
PROVIS AX470 (TRF) Microscope using a Nikon DXM1200 Digital Camera 
and Nikon ACT-1 software. The images were reviewed in Adobe Photoshop 
Elements. 
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2.6.2.2 Van Gieson’s staining 
Sections were rehydrated as described in section 2.6.2.1. Sections were 
stained with Celestine Blue [5% ammonium ferric sulphate (iron alum) with 
5g/mL Celestin Blue] for 5 minutes, and then rinsed in distilled water. Cells 
were stained with Haemotoxylin for 5 minutes, washed well with tap water for 
5 minutes and submerged in Curtis stain for 5 minutes. Sections were then 
blotted to remove excess liquid, rapidly dehydrated through alcohol to Xylene 
and mounted with DPX and coverslips. Images were acquired using an 
Olympus PROVIS AX470 (TRF) Microscope using the Nikon DXM1200 
Digital Camera and Nikon ACT-1 software. The images were reviewed in 
Adobe Photoshop Elements. 
 
2.6.3 Immunohistochemical evaluation of chondrogenic 
differentiation by aggrecan expression 
Pellets after 28 days differentiation were placed into a 30% sucrose solution 
(Sigma®, UK) overnight at 4°C. After pellets had fallen to the bottom of the 
sucrose solution, they were removed from the sucrose solution using forceps, 
and placed onto a cryotome chuck in cryosection embedding media, and 
cooled until set in dry ice. 10μm sections were then cut on the cryotome 
(Cryotome Electronic 77210163, Shandon, UK) and placed on Poly L-lysine 
coated microscope slides (Fisher Scientific, UK). These pellet sections were 
carefully washed with PBS before blocking in a 1:20 dliution of goat serum 
(Santa Cruz, USA) in PBS+0.05% Tween20 (Sigma®, UK), for 30 minutes at 
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room temperature. Sections were incubated in the presence of 1:50 dilution 
of 6B4 mouse anti-aggrecan antibody (kindly donated by Prof. Bruce 
Caterson, Cardiff University School of Biosciences) overnight at 4°C in a 
humidified chamber. The next day slides were washed three times with 
PBS+0.05% Tween20 for 5 minutes, before incubation with an anti-mouse 
secondary antibody (1:50, Dako, UK) for 1 hour at room temperature. 
Sections were washed again with PBS prior to mounting under coverslips 
with Dako fluorescent mounting medium. Images were acquired using an 
Olympus PROVIS AX470 (TRF) Microscope using the Nikon DXM1200 
Digital Camera and Nikon ACT-1 software. The images were reviewed in 
Adobe Photoshop Elements 
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2.7 Osteogenic Differentiation 
To investigate the lineage potential of isolated cell populations, cells were 
induced along the osteogenic lineage by supplementation of culture media 
for 28 days using an established differentiation cocktail (Coelho and 
Fernandes, 2000, Coelho et al., 2000). Cultures were then assessed by 
histochemical staining for calcium deposition using Alizarin red staining. 
 
2.7.1 Osteogenic induction of cell cultures 
Cells were seeded into three 8-well chamberslides (BD Falcon, UK) for 
osteogenic induction and three for control cultures at 3x103 cell/cm2. Cells 
were cultured in DMEM+10%FBS until confluency. At this point the media 
was replaced with osteogenic induction media (Alpha modified Eagles 
medium (α-MEM, Invitrogen, UK) supplemented with 10% (v/v) FCS, 2mM L-
glutamine, 100U/ml penicillin G, 100μg/ml streptomycin sulphate, 0.25μg/ml 
amphotericin B, 50μg/ml L-ascorbate, 10μM dexamethasone and 10μM beta-
glycerophosphate (Sigma, UK)). Cells were also culture in standard 
DMEM+10% FBS media as a differentiation control. Cells were cultured for 
28 days before staining for calcium deposition using Alizarin red. 
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2.7.2 Evaluation of Osteogenic differentiation using Alizarin 
red staining 
After 28 days in either differentiation media or control media, chamber slides 
were washed with PBS and cells fixed with 70% ice cold ethanol for 15 
minutes at -20°C.  
 
Cells were washed with PBS before the addition of Alizarin Red Solution 
[Alizarin Red 20g/L in distilled H2O] at room temperature for 2 minutes. 
Chamberslide culture chambers were removed to reveal the underlying 
microscope slide, which was then in turn mounted with DPX (Sigma®, UK) 
and a coverslip was placed over the slide. After the DPX mount was dry, 
images were acquired using an Olympus PROVIS AX470 (TRF) Microscope 
using a Nikon DXM1200 Digital Camera and Nikon ACT-1 software. The 
images were reviewed in Adobe Photoshop Elements. 
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CHAPTER 3 
The isolation and long term culture of oral 
mucosal progenitor cell populations from 
the lamina propria 
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3.1 Introduction 
 
Fibroblasts derived from the oral mucosa have been known to display distinct 
phenotypic characteristics when compared to fibroblasts obtained from 
human skin particularly in the wound healing process, including lower levels 
of tissue infiltrating immune cells and  increased levels of growth factors 
(Szpaderska et al., 2003, Smith et al., 2010, Shannon et al., 2006, Stephens 
et al., 2001b). In addition, oral fibroblasts demonstrate increased MMP 
activity and an increased ability to remodel extracellular matrix and close a 
wound in vitro (Lee and Eun, 1999, Stephens et al., 2001a). Ultimately these 
phenotypic characteristics play a role in the normally non-scarring wound 
healing process observed within the oral mucosa. It has been postulated that 
these differences in phenotype and the non-scarring wound healing process 
may be in part due to a previously unknown stem cell population resident 
within the oral mucosa (Stephens and Genever, 2007). 
Embryonic stem cells are totipotent cells capable of generating cells from all 
developmental lineages (Keller, 1995). ES cells demonstrate rapid growth 
rates and can be cultured for up to 2 years without exhibiting signs of cellular 
senescence (Fortier, 2005). Whilst the potential for these cells to provide a 
therapeutic benefit for a number of disease conditions is vast, the ethical 
implications of their use, means that embryonic stem cell therapy may never 
become a standard practice. This has lead to research around the world into 
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alternative sources of multi-potential stem cells of non-embryonic origin, and 
the discovery of a number of adult stem cell populations. 
Adult stem cells have been isolated from a number of tissues of different 
developmental origin since the discovery of mesenchymal stem cells in 
peripheral blood by Friedenstein et al in 1970. In vitro characterisation of 
MSCs determined that these cells were able to undergo 40 population 
doublings before exhibiting signs of replicative senescence (Friedenstein et 
al., 1970, Bruder et al., 1997). Other tissues shown to possess adult stem 
cell populations include adipose tissue and cartilage (Alsalameh et al., 2004, 
Hiraoka et al., 2006, Miyazaki et al., 2005, Dowthwaite et al., 2004, Fickert et 
al., 2004). The skin, functionally a similar tissue to the oral mucosa, also 
contains adult stem cell populations (Jones and Watt, 1993, Jahoda et al., 
2003, Toma et al., 2005, Toma et al., 2001). 
In the oral cavity, adult stem cell populations have been found in a number of 
tissues. The dental pulp contains a cell population with the capacity for self 
renewal and the ability to generate dentin-pulp like tissue when implanted in 
mice, and generating adipocytes and neural-like cells in vitro (Gronthos et al., 
2002). Mesenchymal cells isolated from the dental papilla of impacted 
wisdom teeth have also exhibited multilineage potential and the presence of 
stem cell associated markers (Ikeda et al., 2006). Postnatal deciduous teeth 
have also been shown to contain a multipotent stem cell population capable 
of forming neural cells, adipocytes and odontoblasts (Miura et al., 2003). The 
periodontal ligament has also been shown to contain stem cells which have 
an extended capacity for self renewal and positive for stem cell markers 
85 
 
(Trubiani et al., 2005). The lamina propria also contains a keratinocyte stem 
cell population (Izumi et al., 2007, Calenic et al., 2010). All of this data 
suggests that a stem cell population may reside within the lamina propria 
(Davies et al., 2010, Marynka-Kalmani et al., 2010, Zhang et al., 2009, Zhang 
et al., 2010) 
The isolation of adult stem cell populations can be undertaken utilising a 
number of methods, including adherence to plastic in the case of muscle 
derived stem cells (Sinanan et al., 2004) and blood derived MSC (Wagner et 
al., 2005) or through differential adherence to extracellular matrix 
components such as collagen or fibronectin (Jones and Watt, 1993, 
Dowthwaite et al., 2004). This differential adhesion characteristic of stem 
cells allows for clonogenic expansion of single cells giving rise to pure cell 
populations. As previously discussed stem cells demonstrate an increased 
replicative potential in vitro, with MSCs able to undergo at least 50 population 
doublings (Stenderup et al., 2003, Bonab et al., 2006). In the case of MSCs 
when this replicative potential is exhausted and cells exhibit signs of cellular 
senescence, they become larger with an irregular, flat shape, increasingly 
granular cytoplasm and circumcised nuclei when observed using phase 
contrast microscopy (Wagner et al., 2008). 
The aim of this chapter was to successfully isolate a progenitor cell 
population from the Lamina Propria of the Oral Mucosa by the rapid 
adherence of this cell population to fibronectin, and observe the colony 
forming efficiency of those isolated cells. Once isolated these populations 
were compared with both heterogeneous, unseparated cells representing 
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whole lamina propria cultures (LO), and progenitor-depleted cells which did 
not adhere to fibronectin during differential adhesion (NA). These 
comparisons were based on the replicative potential of these cell populations 
during long-term culture, as well as associated changes in cell size as the 
cells reached senescence. 
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3.2 Results 
3.2.1 Isolation of cells from the lamina propria of the oral 
mucosa 
 
Cells were obtained from patients undergoing wisdom tooth extraction after 
ethical approval (LREC 05/WSE02/124) and informed patient consent 
(Chapter 2.2.1). During the extraction procedure, a 6mm section of buccal 
mucosa was excised before proteinase/collagenase digestion and 
subsequent differential adhesion and cell population isolation. In total 5 
patients were consented for the study, shown in table 3.1. Only 2 patients 
were successfully taken from the point of isolation to senescence with 5 cell 
populations, patient XVII and patient XXVIII, male and female respectively. 
The other three patients were unsuccessful for a number of reasons, 
including failure of all cell populations to grow from point of isolation, to 
cultures succumbing to microbial infections.  
The five populations from patient XVII and patient XXVIII represent three 
clonally derived populations obtained by adherence to fibronectin (clone 6, 7, 
10 XVII and clone 3, 9, 10 XXVIII), a population representative of the 
digested lamina propria prior to the differential adhesion assay (LO) and 
those cells which did not adhere during the sequential adherences 
incubations (NA). All subsequent experiments concern the comparative 
properties of these 5 populations from patient XVII and XXVIII. 
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3.2.2 Differential Adhesion and Colony Forming Efficiency 
After collagenase digestion of the mucosal biopsy, cells were used in a 
differential adhesion assay (See Chapter 2.2.2). Initial adhesion to fibronectin 
was recorded after 24h and compared with BSA controls (Fig 3.1A). This 
data represents the combined data from patients XXVIII, XXXVI and XXXVIII. 
The adherence to fibronectin was measure over 1 hour and 40 minutes, at 
three timepoints: 20 minutes (FN20), 40 minutes (FN40 [1]) and a further 
second 40 minutes (FN40 [2]). At 20 minutes, fibronectin demonstrated a 
significantly higher level of adherence than BSA controls when analysed 
using a one-way ANOVA with a Bonferroni multiple comparisons post test 
(P<0.001). In addition, the 20 minute incubation also demonstrated a 
significantly higher adherence when compared to the other fibronectin 
timepoints (P<0.001 in both instances). After the initial adherence, cells were 
cultured for 12 days and colonies in excess of 32 cells (Fig 3.2B) were 
counted at days 5, 9 and 12 to determine colony forming efficiency (CFE - by 
dividing number of colonies by initial adherence). Comparisons were made 
between fibronectin at 20, 40[1] and 40[2] timepoints at these three intervals 
(Fig 3.2). At Day 5 only the FN20 timepoint demonstrated any colony 
formation. By day 9 however, all three timepoints exhibit colony formation. By 
day 12 the difference in CFE was significant between FN20 and FN40 [2], 
with the FN20 timepoint giving rise to a CFE at 0.042 (p<0.01). Colonies 
were removed from the culture plates after the day 12 measurement and 
cultured as clonally derived cell populations originating from a single seeded 
cell. 
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In summary, the adherence to fibronectin was significantly higher than BSA 
controls, and fibronectin adherence decreased across the three sequential 
timepoints significantly. Differences in CFE do not become highly significant 
during the first 9 days of the assay, but by day 12 the FN20 timepoint 
demonstrates a significantly higher level of colony formation when compared 
to FN40 [1] and FN40 [2]. 
 
3.2.3 Growth Kinetics of Isolated cell populations 
After isolation of clonally derived cell populations (clone x) and alongside the 
other populations isolated as mentioned previously, cells were cultured long-
term as described in materials and methods (Chapter 2.2.3). Three clones 
which demonstrated the highest growth rate during the intial passage were 
selected for culturing until senescence, with the remainder frozen for future 
use. Growth kinetics for all cell populations were plotted for both patient XVII 
(Fig 3.3) and XXVIII (Fig 3.4) from isolation until senescence, a pre-
determined threshold of three repeated passages at a rate of less than 0.5 
population doublings per week was used for this point. In patient XVII (Fig 
3.3), all clonally derived populations demonstrated a rapid initial phase of 
growth after isolation, XVII clone 6 underwent 76 population doublings (PD) 
over 597 days, the highest number of population doublings for a clone from 
this patient. All three clones exhibited similar growth kinetics over the first 20 
PD; however, after this time clone 7 demonstrated a diminished growth rate 
for 100 days before an increase in growth rate back to similar levels to those 
observed in clone 6.  Clone 10 however, exhibited signs of senescence after 
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37 population doublings. The LO and NA populations differ in growth kinetics 
to the clonally derived populations, initially demonstrating a low rate of growth 
before an increase in growth kinetics was observed around 100 days. The 
LO population achieve the highest number of population doublings, with a 
growth rate consistently higher than the NA population. Also of note was the 
“stepped” growth rate with many increases and decreases in growth rate in 
the LO population.  The LO and NA populations achieved 91 and 73 PD over 
650 and 633 days respectively. When comparing average growth rates over 
the entire replicative lifespan of the cell populations (Table 3.2), it is apparent 
that the LO and NA populations demonstrate a higher average growth rate, 
and over their entire lifespan, the LO population were the cells with the 
highest replicative potential. 
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Patient XXVIII population doublings follow a similar trend to those seen in 
patient XVII however, the cell populations did not achieve the same levels, 
with the highest PD being observed in LO XXVIII, however (Fig. 3.4, Table 
3.2) only achieving 76 PD over 417 days. In terms of the growth kinetics 
however, the pattern of the clonally derived populations rapidly achieving 20 
PD before slowing in rate are maintained across the two patients, as was the 
lag in the growth of both the LO and NA populations before an increase in 
proliferation rate. The NA population also demonstrated a reduction in 
proliferation in line with the clonally derived population toward the end of their 
replicative lifespan.  
 
The average growth rate of the XXVIII populations when compared to those 
of patient XVII were consistently higher, with the clonal growth rates 
comparable to the LO and NA rates from XVII (1.3, 1.2 and 0.9 PD/week 
respectively), however, the LO and NA rates were again higher than those 
observed in the clones for patient XXVIII, with the LO XXVIII population 
exhibiting the highest average growth rate of 1.57 PD per week. As with 
patient XVII, one of the clones did not grow in the same way as the others, 
Clone 10 XXVIII. This clone showed a marked decrease in proliferation after 
20 PD however, it did overall achieve 57 population doublings before 
entering senescence, similar to that observed in clones 3 and 9, but with a 
lower average growth rate. In summary, whilst the final number of divisions 
between patients differs, the growth kinetics of the different cell populations 
seem to exhibit distinct characteristic maintained between patients, with the 
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heterogeneous populations (LO and NA) demonstrating higher growth rates 
and a higher number of population doublings over the lifetime in culture. 
 
3.2.4 Maintenance of Long Term Cultures 
Over the replicative lifespan of all the cell populations, routine testing for 
Mycoplasma was conducted using Hoechst staining as described in the 
materials and methods (Chapter 2.2.4) at every other passage. Briefly, cells 
were stained with a DNA intercalating dye and visualised under fluorescence 
microscopy. Any cells contaminated with Mycoplasma exhibited a „speckled‟ 
staining throughout the cytoplasm. Cells which were negative for 
Mycoplasma infection demonstrate nuclear-only staining. When conducting 
this routine Mycoplasma staining (Fig 3.5), samples from XVII were found to 
be positive for Mycoplasma contamination (Fig 3.5a). These cells were then 
treated with alternating tetracycline derived antibiotics (BM Cyclin 1 &2) for 
three weeks as recommended by the manufacturer, after which time the cells 
were retested and found to be negative (Fig 3.5b) for non-nuclear staining 
and were then cultured as normal. Samples from Patient XXVIII were found 
to be routinely negative for Mycoplasma testing throughout their replicative 
lifespan. 
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3.2.5 Morphological changes in isolated cell populations 
during long-term culture 
To determine how long-term culture may affect the morphology of these cell 
populations, images were captured at every passage as described in the 
materials and methods (Chapter 2.2.5). The cell images at both early and 
late passages were used for analysis of morphological changes in terms of 
an increase of cell size using ImageJ, using a haemocytometer image at the 
correct magnification to set the scale. Once the correct scale was set, 50 
cells were traced by hand to calculate an average cell area in µm2 as 
demonstrated in Fig 3.6. Images of each cell population at early and late 
passages are shown in Fig 3.7 and 3.8 for patient XVII and XXVIII 
respectively. A visual analysis of the images for each cell population 
demonstrated that all cell populations appear initially like small bi-polar 
„fibroblast-like‟ cells with minimal cellular processes.  However, by the late 
passages these cells are visually larger, exhibiting roughened edges with 
more branched cellular processes, as observed for example in clone 10 
XXVIII (Fig 3.8).  
 
  
101 
 
  
102 
 
  
103 
 
104 
 
The cell size data was analysed for any statistical significance by Kruskal-
Wallis non-parametric One-way Analysis of Variance (ANOVA) with a Dunn‟s 
post test conducted where P<0.05, as data was not normally distributed and 
therefore failed the assumptions necessary for a parametric statistical test. 
Graphs were plotted showing the average cell size for both early and late 
passages of all cell populations from patients XVII and XXVIII (Fig 3.9 and 
Fig 3.10). All cell populations from patient XVII demonstrated a significant 
increase in cell size over their replicative lifespan, with the exception of clone 
10 XVII which saw no significant increase in cell size during time in culture 
before undergoing cellular senescence. All these results were highly 
significant (P<0.001), and confirm the visual analysis of morphological 
changes observed in the cell images. When comparing cell populations from 
patient XVII at the early passage, there were no significant differences in cell 
populations however, there were significant differences between cell 
populations at the late passage, with Clone 6 XVII cells exhibiting a larger 
cell area than Clones 7 and 10 respectively (P<0.05 and P<0.001), but not 
the LO or NA populations.  
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3.3 Discussion 
The aims of this chapter were to isolate multiple cell populations from the 
Lamina Propria of the Oral Mucosa by differential adhesion to fibronectin, 
and investigate  if any differences in growth kinetics and cellular morphology 
exist between these different cell populations during long term culture. 
Previous work within the Wound Biology Group, School of Dentistry, Cardiff 
University demonstrated the increased replicative potential of oral mucosal 
fibroblasts in vitro (Enoch et al., 2009), a heterogeneous cell population with 
which no selection by differential adherence prior to culture was conducted. 
The question of whether clonally expanded cells still exhibit an increased 
replicative potential is important in understanding the mechanism behind the 
oral fibroblast‟s longevity in vitro. Changes in cellular morphology with in vitro 
ageing are also important to address the question of whether these isolated 
cells are stem cells, as changes in cell size have already been observed in 
MSC populations (Wagner et al., 2008). 
Successful isolation of all required cell populations for comparison proved 
problematic in three of five patients for a number of reasons. Infection of 
initial cultures from patient XXII lead to the loss of those cells cultured from 
this patient. The oral cavity has a diverse collection of microflora and while 
attempts were made to ensure any microbes were sterilised from the lamina 
propria biopsies prior to tissue disaggregation.  However, in this instance it 
became apparent that an opportunistic pathogen was able to colonise the 
culture media preventing growth of any cells for comparison. Patients XXXVI 
and XXXVIII also failed to produce NA populations and where therefore not 
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suitable for comparisons between cell populations. The reasons for this 
observed difference in the ability to form non-adherent cell populations 
between patients are unclear. Age does not appear to be a factor as patient 
XXVIII, which successfully produced a NA population and patients XXXVI 
and XXXVIII, which did not were all born within 2 years, whilst the other 
successful patient (XVII) was at least 10 years older. Patient to patient 
variability may be responsible however, proving this would require a much 
larger data set. Attempts to get another biopsy to bring the number of 
samples to 3 after the unsuccessful biopsies were not possible in part due to 
lack of eligible patients attending clinic, and time constraints of obtaining a 
sample and culturing to senescence meant that it was not possible in the 
time remaining. 
Using the differential adhesion to fibronectin demonstrated a significant 
number of cells were able to adhere during the first 20 minute incubation 
compared to the corresponding BSA coated control, and compared to the 
subsequent 40 minute incubations on both fibronectin and BSA. This can be 
explained by high levels of functional α5β1 integrin expressed on the surface 
of those cells which adhere to the fibronectin coated wells after 20 minutes, 
as the „classical‟ fibronectin receptor (DeSimone et al., 1992). In the BSA 
coated controls, adherence occurs via non-specific interactions and will not 
select for a cell with higher levels of integrin expression, explaining the 
consistent levels of adherence observed at all timepoints to BSA . 
This increased integrin expression has been observed in progenitor cells 
isolated from articular cartilage (Dowthwaite et al., 2004) however, it is 
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suggested that higher integrin expression does not provide an indicator of 
colony forming efficiency of adherent cells. In this study however, those cells 
which adhere rapidly, perhaps due to higher levels of integrin expression, 
demonstrated a higher colony forming efficiency. Quantification of integrin 
expression would be a useful addition to the current data to determine if the 
integrin expression is truly responsible for the adherence characteristics, and 
a potential marker of those cells with a high replicative potential. 
The growth kinetics of both patients observed demonstrated similar kinetic 
profiles. In both patients the clonally derived cell populations underwent a 
brief phase of high proliferation, achieving 7/10 population doublings in 16/13 
days for patient XVII and patient XXVIII respectively. This rapid burst in 
proliferation is probably due to the clonal nature of these cell populations and 
the high number of cell divisions to achieve a cell population similar in size to 
those observed in the NA/LO populations. Interestingly in both patients clone 
10 did not follow the same kinetic profile as the other clones, in the case of 
patient XVII only reaching 35 population doublings before entering cellular 
senescence. These clones were both initially frozen after two passages, as 
each patient generated more clonally derived cell populations than required 
and only three clones were selected to be culture until senescence. However, 
when one of the clones selected in each patient senesced early, suggesting 
they were transit amplifying cells (Bluteau et al., 2008), clones 10 XVII and 
XXVIII were thawed out and cultured as replacements for these senescent 
cell populations, and this may be responsible for the retarded growth kinetics 
of these cell populations. In the instance of clone 10 XXVIII however, it was 
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able to still achieve in excess of 50 population doublings whereas clone 10 
XVII was only able of achieving 35 population doublings.  Notably  this is still 
higher than reported for  some MSC populations where only 27 population 
doublings were achieved (Bieback et al., 2004). With the exception of clones 
10 XVII and XXVIII, this differential adhesion and clonal selection assay 
demonstrated a method by which higher proliferative cells with replicative 
potential similar or greater than MSC populations can be successfully 
isolated. This clonal selection allows for a pure cell population 
uncontaminated with transit amplifying and terminally differentiated cells, and 
this has been shown to increase the differentiation potential (Kotobuki et al., 
2004). After this initial phase the clonal population growth rates decreased 
until reaching a rate similar to that observed in the NA population. The LO 
population however, maintained consistent growth kinetics throughout their 
replicative lifespan, similar to those observed previously within the Wound 
Biology Group‟s reports on oral fibroblast replicative potential (Enoch et al., 
2009). The heterogeneous nature of this cell population may enhance the 
replicative potential of the resident stem cell population by allowing them to 
remain quiescent and only dividing when those terminally differentiated cells 
become senescent and effectively „drop out‟ of the proliferating population. 
This may explain the higher number of population doublings achieved before 
senescence was observed within the LO populations of both patients. 
Comparisons of the average growth rates for cell populations show an 
interesting phenomenon. In both patients the average growth rate of the 
clonal populations was lower than the NA populations, which in turn were 
lower than the LO population. This is interesting given the high growth rates 
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in the clones during early passages, meaning the LO/NA populations are 
consistently achieving a higher growth rate over the lifespan of these 
cultures, compared to the clonal populations.  
During the culture life of these cells routine Mycoplasma testing was 
conducted to detect and subsequently eradicate any infections. Mycoplasma 
has been shown to alter the behaviour of cell cultures (Hendershot and 
Levitt, 1985, Levine et al., 1968) and MSC have been found to be efficient 
vectors of Mycoplasma infection (Zinocker et al., 2011). During this routine 
screening all cell populations from patient XVII were found to be positive for 
Mycoplasma as determined by the non-nuclear localised staining with 
Hoechst fluorescence dye. Cells were immediately quarantined from all 
Mycoplasma negative cells and treated with tetracycline derivative antibodies 
as recommended by the manufacturer until testing demonstrated nuclear 
only staining, and therefore Mycoplasma contamination was eradicated. This 
allows the conclusion that all of the subsequent analysis of these cell 
populations is a result of the behaviour of the cells in question and not an 
artefact of Mycoplasma contamination.  
The final analysis undertaken on cell populations was to determine the effect 
of long term culture and ensuing senescence on the cell morphology/cell 
area. When cells undergo replicative senescence, their morphology changes 
as reported for skin fibroblasts and MSC (Gorbunova et al., 2003, Wagner et 
al., 2008, Stephens et al., 2003, Baxter et al., 2004). With the exception of 
Clone 10 XVII, all cell populations demonstrated a significant increase in cell 
area over time in culture, with cell morphology changing from a classical 
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fibroblastic, spindle bi-polar morphology to a larger, more flattened 
morphology with an increase in cellular processes. The replicative potential 
of the cell populations appears to have no bearing on the cell size at 
senescence, but with data for only two patients any conclusions drawn are 
limited; the analysis of populations from a larger number of patients may 
highlight the importance of patient variability or identify a trend within the data 
which cannot be elucidated at present in this thesis. 
The data presented in this chapter demonstrates that the differential 
adhesion assay allows for the selection of clonally derived cell populations 
which have a high replicative potential, and demonstrate distinct growth 
characteristics when compared to more heterogeneous unselected cell 
populations. This selection may be due to the higher level of α5β1 integrin 
expression on the surface of cells allowing for more rapid adherence during 
this assay (Jones and Watt, 1993, DeSimone et al., 1992). Without further 
analysis of integrin expression to determine if these cells do show differential 
expression of integrins, it is not possible to draw conclusions on this.  With 
some exceptions, all cell populations were able to exceed 50 population 
doublings in vitro, higher than those observed in normal somatic cells and in 
particular MSCs cells (Baxter et al., 2004, Banfi et al., 2000, Bruder et al., 
1997, Hayflick, 1965).  This suggest that all cell populations have a high 
capacity for self renewal, and that in the instance of the lamina propria this 
may be a characteristic of all cells resident within the tissue, not just of stem 
cells. Changes to cell morphology and the associated increase in cell area 
follow the characteristics of both fibroblasts and stem cell populations and 
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suggest that the cell populations isolated from the oral mucosa behave in a 
traditional manner. At this stage without further characterisation, the nature of 
these populations and the presence of stem cells are uncertain, and hence 
the characterisation and differentiation studies within the next chapters will 
address these issues. 
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CHAPTER 4 
The characterisation of cell populations 
isolated from the oral mucosa lamina 
propria  
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4.1 Introduction 
The ethical and moral issues surrounding the use of pluripotent embryonic 
stem cells (ESCs) have led to an increased level of interest in adult stem cell 
populations (ASCs). To date, these adult stem cells have been identified from 
multiple sites within the body however, those cells which have been most 
characterised remain those first identified, namely bone marrow stromal cells 
(BMSCs) (Yoo et al., 2005, Wagner et al., 2005, Quirici et al., 2002, Oliveira 
et al., 2009, Mareschi et al., 2006, Mareddy et al., 2007, Ishii et al., 2005, 
Friedenstein et al., 1970). Adult stem cells have been successfully isolated 
from a number of other tissues including oral tissues (Otaki et al., 2007a, 
Ikeda et al., 2006, Gronthos et al., 2002, Webb et al., 2004, Toma et al., 
2005, Toma et al., 2001, Fernandes et al., 2004, Chunmeng et al., 2004, 
Nakamura et al., 2007, Izumi et al., 2007, Calenic et al., 2010). 
Characterisation of these isolated stem cell populations often includes 
immunophenotyping of cell populations for the presence of specific cell 
surface markers such as CD90, CD105, CD166 and STRO-1 (Table 1.3, 
Chapter 1.7.2) and the absence of markers such as CD34 and CD45 to 
ensure that those cells are not of haematopoietic or fibrocyte origin 
(Nagatomo et al., 2006, Pasquinelli et al., 2007, Song et al., 2005, Diaz-
Romero et al., 2005).  
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The expression of active telomerase is also suggested as a stem cell marker, 
with telomerase expression well characterised in embryonic stem cells (Heins 
et al., 2004, Thomson et al., 1998). It is also implicated in a large number of 
cancers (Herbert et al., 2001, Kishimoto et al., 1998, Poremba et al., 2000, 
Tatsumoto et al., 2000).  The subject of adult stem cells and telomerase 
activity is at present unclear, with reports of telomerase activity in adult stem 
cells reported by groups contradicted by the findings of others. A sub-
population of haematopoietic progenitors from adult human bone marrow has 
been shown to possess telomerase activity in vitro (Chiu et al., 1996). 
Telomerase activity has also been observed in human neural precursor cells 
(Ostenfeld et al., 2000). However, no telomerase activity has yet been found 
in bone marrow stromal cells (Fehrer and Lepperdinger, 2005, Zimmermann 
et al., 2003).  
Telomerase is an enzyme responsible for the maintenance of telomeres, the 
large regions of repetitive DNA at the ends of chromosomes. The lack of 
telomerase is associated with premature ageing; the erosion of telomeres in 
vitro is one mechanism responsible for replicative senescence (von Zglinicki, 
2002, Harley et al., 1990, Baxter et al., 2004, Shay and Wright, 2007). Work 
carried out within the Wound Biology Group has previously shown that oral 
fibroblast lifespan is telomerase independent (Enoch et al., 2009). Current 
work into the isolation of stem cells from the Lamina Propria has 
demonstrated that colonies formed from single cells using differential 
adhesion express telomerase by immunocytochemistry and this in part 
explains the ability of these cells to rapidly proliferate and form colonies in 
vitro (Davies et al., 2010). 
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The aim of this chapter is to confirm the presence of stem cell associated cell 
surface markers by flow cytometry, to confirm the phenotype of these 
isolated cell populations conform to that observed in other adult stem cell 
populations within the literature. Secondly, the quantification of telomerase 
activity will allow comparisons between cell populations and determine if 
clonal expansion enriches a cell population for increased telomerase activity. 
The final analysis of this chapter will be to determine the level of telomere 
erosion occurring with in vitro ageing within the different cell populations. All 
of this analysis will be conducted to determine if differential adhesion 
enriches the clonal cell populations for these stem cell associated markers, 
or whether an unselected, heterogeneous cell population is phenotypically 
similar in terms of telomerase, protein expression and telomere maintenance. 
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4.2 Results 
 
4.2.1 Flow cytometry detection of stem cell associated 
markers 
Cells were analysed for expression of stem cell markers CD90, CD105 and 
CD166 and negative markers CD34 and CD45 as described in the materials 
and methods (Chapter 2.2) at the earliest passage possible to generate a cell 
number sufficient for the experiment. In the Clone populations, the cells were 
used at passage 4 (~20 PD), with population doubling matched LO/NA cells. 
These markers were selected due to their consistency among the scientific 
literature, where an abundant number of markers are used to determine the 
presence of a stem cell population. Fig 4.1-Fig 4.10 demonstrates the 
expression of these markers in each cell population by flow cytometry, where 
the red histogram peaks represent mean fluorescence intensity (MFI) of the 
isotype control antibody, and the blue histogram represents the mean 
fluorescence of the corresponding cell surface marker. In each figure, graph 
F represents the morphological characteristics defined by the forward and 
side scatter (FSC and SSC). This graph determined the gating strategy for 
subsequent analysis of marker expression. Typically, the mean fluorescence 
of CD34 and CD45 after isotype control subtraction was negative, indicating 
that those cells were negative for those markers. However in three instances 
(10 XXVIII, LO XXVIII and 6 XVII) demonstrated a very small shift in mean 
fluorescence even after isotype subtraction in both CD34 and CD45, with 6  
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XVII showing the highest shift in CD34 (3.72) and LO XXVIII recording a 
fluorescence shift of 7.86 (CD45). The analysis of CD90, CD105 and CD166 
demonstrate different expression profiles between patient XVII and XXVIII. 
Patient XVII demonstrated higher MFIs for CD90 in the LO and NA 
populations (79.5 and 75.5 respectively) than observed in the clonal 
populations, with clones 6, 7 and 10 giving MFIs of 37.9, 6.26 and 60.91 
respectively. Interestingly, the corresponding MFIs in patient XXVIII were the 
inverse, with the clonal populations having MFIs of 51.08, 45.4 and 68.37 for 
clones 3, 9 and 10 XXVIII respectively; which were higher than LO and NA 
populations for CD90, at 25.37 and 4.13 respectively. The MFI for CD105 
from patient XVII again demonstrated higher MFIs in the LO and NA 
populations than the clonal populations with MFIs of 108.8 and 124.46, with 
the exception of 6 XVII which had an MFI similar to the LO and NA 
populations, at 114.67. In patient XXVIII the MFI for CD105 were higher in 
the clonal populations than in the LO and NA populations. The final CD 
marker, CD166 demonstrated variable expression in both patients, with the 
highest MFI in patient XVII observed in the NA population at 93.3, and the 
lowest at 11.8 in 7 XVII. The MFI for 6, 10 and LO populations from patient 
XVII were all similar, at 63.04, 69.56 and 68.21 respectively. In patient 
XXVIII, the highest MFIs were in 9 XXVIII and LO XXVIII (98.21 and 96.36) 
with the lowest MFI observed in the NA population at 6.54. It is worth noting 
that the MFI in the NA XXVIII population for all positive markers is very low 
by comparison to all other populations (Table 4.1). 
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4.2.2 Quantification of telomerase activity in cell lysates 
using the QTRAP assay 
To determine the presence of telomerase within cell lysates, the telomeric 
repeat amplification protocol was initially utilised. However the technique 
lacked the sensitivity to detect low levels of telomerase activity which may be 
present in heterogeneous cell populations such as the LO and NA 
populations, and did not detect telomerase in all clonally derived cell 
populations (see Appendix Fig 8.1 and 8.2). Instead, a quantitative PCR 
based detection method based on the SybrGreen reagents was 
implemented, known as the QTRAP assay (Wege et al., 2003). The method 
is described in full in the materials and methods (Chapter 2.2.6). Cell lysates 
were analysed in triplicate at early, mid-stage and late passages to elucidate 
and changes in telomerase activity during the replicative lifespan of the cell 
populations in vitro. Data was analysed using one way ANOVA with a 
Tukey‟s ad-hoc test where p<0.05. 
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The level of telomerase activity in individual cell populations was investigated 
first (Fig 4.11). Clone 6 XVII does not show a significant change during time 
in culture (P>0.05). Clone 7 XVVI exhibits a significant increase in 
telomerase activity at the mid-stage of its replicative lifespan (p<0.01), before 
significantly decreasing back to similar levels as observed in the early 
timepoint by the late time point (p<0.001). Clone 10 XVII shows no change in 
telomerase expression (P>0.05). LO XVII cells demonstrated telomerase 
activity similar to 7 XVII with a peak at the mid time point (p<0.01) before 
falling back to a similar level at the late time point (p<0.05), however the peak 
telomerase activity is still lower than recorded in 7 XVII (p<0.05). The NA 
XVII population maintains similar levels at early and mid time points before a 
significant reduction in telomerase activity by the late timepoint (p<0.05). 
Comparisons between the cell populations at early time points demonstrated 
that only 6 XVII expressed higher levels of telomerase (p<0.05),  At the mid-
stage in patient XVII cell populations in vitro lifespan, 7 XVII expressed 
higher levels of telomerase than all other cell populations (all p<0.05, 
p<0.001 for 6 XVII), whilst LO XVII expresses a higher level of telomerase 
than 6 XVII  (p<0.05). By the late time point, levels of telomerase are similar 
across all cell populations (p>0.05). 
In patient XXVIII, Clone 3 demonstrates no change in telomerase activity 
across the three timepoints (Fig 4.12, p>0.05). Clone 9 XXVIII demonstrates 
a significant increase between early and late time points (p<0.05), whilst 10 
and LO XXVIII demonstrated a significant decrease (p<0.05). NA XXVIII 
demonstrate a drop in telomerase activity at the mid time point, which then 
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returns to early levels by the late time point (p<0.05). Comparisons between 
cell populations demonstrated that at the early time point, 3 XXVIII expressed 
higher levels of telomerase than  9, 10 and LO XXVIII respectively (p<0.001, 
p<0.01, p<0.05, respectively), but not NA XXVIII (p>0.05). At the late time 
point, 9 XXVIII expresses higher levels of telomerase than 10 XXVIII and LO 
XXVIII (p<0.05). 
To confirm the results of the QTRAP assay were due to the amplification of 
the telomeric substrate, the products of the reaction were resolved on an 
acrylamide DNA gel. The results shown in Fig 4.13 and Fig 4.14 samples 
from patient XVII and XXVIII at early time points, with heat-inactivated 
controls to demonstrate that dentaturation prior to the reaction abolished 
telomerase activity. The laddered banding is distinctive of telomerase activity, 
representing a 6bp extension of the original 50bp TS primer substrate. This 
occurs multiple times giving rise to bands increasing incrementally  by 6bp. 
Faint banding is observed however even in the heat inactivated controls and 
the buffer control (CHAPS), as a small amount of primer dimerisation is 
unavoidable in this assay. The strong, dark banding observed in the 501mel 
positive control and in the XVII lysates is typical of those seen using the 
QTRAP and TRAP assay. 
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4.2.3 Quantification of telomere length by terminal restriction fragment 
(TRF) assay 
The analysis of telomere length was conducted using the terminal restriction 
fragment (TRF) using the TeloTAGGG assay, to determine if the presence of 
active telomerase as determined using QTRAP was capable of telomere 
maintenance  in culture. This assay gives an estimate of telomere length 
through the visual representation of a smeared band of DNA on a 
hybridisation membrane (Chapter 2.4). By measuring the top and bottom of 
each band and determining the median telomere length, comparisons can be 
drawn between telomere length at early, mid-stage and late time points 
corresponding to the replicative lifespan of the cell population, and between 
cell populations from both patients (Fig 4.15, Table 4.2) 
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Clone 6 XVII shows an increase in median telomere length by the late time 
point from 8.8 kilobases (kb) to 10.38kb however, at the mid-point 
demonstrated a reduction in telomere length to 5.66kb. Clone 7 XVII 
exhibited erosion of telomere length from 11.35kb at the early time point to 
5.05kb by the late time point. Clone 10 XVII demonstrated an increase in 
median telomere length. Both LO and NA populations exhibited similar early 
and late telomere lengths of 10.25kb and 10kb at the early and 7.60kb at the 
late timepoint respectively. In patient XXVIII all cell populations begin with 
similar telomere lengths of 11.70, 11.90, 12.80, 13.10 and 12.70 for 3, 9, 10, 
LO and NA XXVIII respectively. Clone 3 XXVIII demonstrated an increase in 
telomere length overall, peaking at the midpoint of 12.95kb before decreasing 
to 12.55kb by the late time point. Clone 9 XXVIII maintained the telomere 
length until the late timepoint where it decreased to 11.3kb. Clone 10 XXVII 
exhibited a decrease in telomere length over the three time points, reaching 
10.98kb by the late time point. The LO and NA populations however, 
demonstrated a dramatic reduction in telomere length reaching 7.63kb and 
6.75kb respectively. 
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4.3 Discussion 
The aims of this chapter were to compare the isolated cell populations in 
terms of the presence of stem cell associated markers CD90, CD105 and 
CD166 and the presence of active telomerase. In addition, investigations into 
the levels of telomere erosion with in vitro ageing were conducted to 
determine whether senescence was telomere-dependent in the different cell 
populations, and if the effects of telomere erosion were linked to levels of 
active telomerase. 
Flow cytometry data demonstrated varied levels of expression of CD90, 
CD105 and CD166 in the cell populations from both patients, with the 
patterns observed between patients XVII and XXVIII in terms of MFI. 
However, all cell populations proved positive for the markers CD90, CD105 
and CD166 in line with the classical definition of mesenchymal stem cells 
(Dominici et al., 2006). These cell surface markers have been found in stem 
cells from multiple origins including bone marrow, periodontal ligament, 
dental pulp, cartilage, synovial fluid and adipose tissue (Trubiani et al., 2010, 
Wada et al., 2009, Tomokiyo et al., 2008, Gay et al., 2007, Nagatomo et al., 
2006, Hiraoka et al., 2006, Fickert et al., 2004, Dowthwaite et al., 2004, 
Alsalameh et al., 2004, Zannettino et al., 2008, Ikeda et al., 2006, Morito et 
al., 2008). Interestingly the presence of these markers had been previously 
discussed in regard to buccal mucosal fibroblasts (Lindroos et al., 2008). In 
this instance they were considered to be a control population, with the 
exception of the CD marker expression, a non-stem cell population. In terms 
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of presentation of this data in the scientific literature, the normal format of 
flow cytometry data is to show a positive shift on histograms as seen in Fig 
4.1 In this manner, the important factor to observe here is that all cell 
populations are positive, and those observed variations in MFI may not be 
important in terms of their stem cell phenotype. This suggests that the 
differential adhesion of fibronectin may not be sufficient to completely remove 
progenitors from within the NA population, and that subsequent cultures will 
enrich for this cell population over time as senescent cells are removed from 
the replicating cell “pool”. This evidence supports data published on oral 
mucosa stem cells cultured by explantation in SCID mice, and work carried 
out within the Wound Biology Group (Davies et al., 2010, Marynka-Kalmani 
et al., 2010).  An interesting finding was the presence of a shift in MFI in 
CD34 and CD45 in three cell populations (6 XVII, 10 XXVIII and LO XXVIII). 
These cell populations were not expected to express these markers, as the 
presence of a haematopoietic cell lineage should be prevented by the culture 
conditions, which are not optimised for this cell type. However, these values 
were extremely low and may just represent experimental error/variation. 
Analysis of the telomerase activity of cell lysates using the QTRAP assay 
allowed for quantification of telomerase activity relative to 501mel, a cancer 
cell line with high levels of telomerase activity. All cell populations expressed 
active telomerase, with distinct differences arising between cell populations. 
Of particular interest was the presence of telomerase within LO and NA 
populations. In patient XVII, the mid time points of both LO and NA 
populations demonstrated increased telomerase activity suggesting that by 
the mid stage of culture an increase in the proportion of progenitor cells 
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within these populations, as a possible explanation for this increase. Clone 
10 XVII, cells which senesced early at only 35 population doublings; do not 
appear to demonstrate any changes in telomerase activity, suggesting their 
senescence was telomerase independent. This has been reported previously 
in oral fibroblasts and may be responsible in this instance, however in that 
study telomerase activity could not be detected in oral fibroblasts, an 
analogous population to the LO population characterised in this thesis 
(Enoch et al., 2009). The telomerase activity detected in patient XXVIII did 
not reflect those difference of patient XVII, differences in telomerase activity 
between cell populations limited to a higher level of telomerase in Clones 3 
and 9 at the early timepoint, an increase which by the late timepoint was only 
apparent between Clone 9 and LO populations.  A larger investigation 
involving more patient samples is required to determine the presence of a 
characteristic telomerase “signature” within the stem cell populations. The 
presence of telomerase within these cell populations is another indicator of 
stem cell phenotype. Mesenchymal stem cells have not demonstrated active 
telomerase (Zimmermann et al., 2003), however, this has been observed in 
other lineages, such as a subpopulation of haematopoietic progenitors and 
neural precursors (Chiu et al., 1996, Ostenfeld et al., 2000, Haik et al., 2000, 
Wang et al., 2010). Most importantly, telomerase activity has been identified 
in cells of the inner cell mass of human blastocysts, the area from which 
ESCs are isolated (Heins et al., 2004, Thomson et al., 1998). Here the 
maintenance of telomere length is responsible in part for the unlimited 
potential for self renewal, one of the defining characteristics of totipotent stem 
cells such as ESCs (Amit et al., 2000). This data suggests that the cell 
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populations from the oral mucosa demonstrate a more pluripotent phenotype 
that MSC phenotype, and further investigation into the differentiation potential 
and plasticity of these cell populations would be crucial to fully understand 
the use of these cells in a therapeutic context for tissue engineering 
purposes. 
The final analysis conducted in this chapter was of telomere 
erosion/maintenance of telomere length using the terminal restriction 
fragment assay (Chapter 2.2.7). This assay gives a representation of the 
telomere length of DNA extracted from cell lysates by the production of a 
smeared band on a membrane after DNA hybridisation. To calculate the 
median telomere length, measurements were taken of the upper and lower 
limits of the observed bands, and the median taken from this value. The 
results showed variation between the telomere lengths at all time points, with 
no discernable pattern of telomere erosion detected, and even in the instance 
of 6 XVII, 10 XVII and 3 XXVIII an observed increase in median telomere 
length. Clone 9 XXVIII, expressing a stable level of telomerase expression 
throughout the replicative lifespan of the cell population, demonstrated 
maintenance of telomere length. When taken in context of the telomerase 
activity of these cell populations, upregulation of telomerase expression in LO 
and NA populations from patient XVII at the mid time point suggest that this 
allows the recovery of telomeres, but ultimately not escape from replicative 
senescence. In Clone 7 XVII, a large increase in telomerase activity has no 
effect on telomere erosion. Clone 10 XVII, senescent after only 35 population 
doublings demonstrated a large increase in telomere length by the late time 
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point, when the cells were actually senescent, however this was not enough 
to escape replicative senescence. The observed increase in telomere length 
and indeed telomerase activity within the samples may be due to culture 
selection of progenitors with longer telomeres, or by the loss of cells with 
smaller telomeres causing an increase to the median, rather than reflecting a 
real upregulation of telomerase within the whole cell population. The 
detection of telomere shortening has been linked with rapid in vitro ageing in 
MSC and is one of the mechanisms responsible for replicative senescence 
(Baxter et al., 2004, Rubin, 2002, Wagner et al., 2008, Hayflick, 1965). 
However in this study it is clear that particularly in the case of 6 XVII, 10 XVII, 
and 3XXVIII, another mechanism of senescence was employed. 
The TRF assay, a crude method to determine telomere length has been 
surpassed by sensitive techniques which allow a higher level of 
quantification. Single telomere length analysis (STELA) is a method by which 
accurate measurements of the full spectrum of telomere lengths from 
individual chromosomes (Baird et al., 2003). This technique has previously 
been utilised for investigation of in vitro ageing in oral fibroblasts (Enoch et 
al., 2009). However for this investigation it was not used due to practical 
difficulties experienced by other researchers in the Wound Biology Group 
with respect to consistent experimental repetition. In future studies it would 
benefit the research if a more exact quantification of telomere erosion could 
be conducted. 
The aims of this chapter were to investigate the presence by flow cytometry 
of CD90, CD105 and CD166, commonly used stem cell surface markers 
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used in the identification of MSCs and other adult stem cell populations. The 
comparison of relative telomerase activity within the different cell populations 
was conducted to determine if clonal expansion of fibronectin adherent cells 
were enriched for this stem cell associated marker. The final analysis was to 
determine the levels of telomeric degradation occurring with in vitro ageing to 
determine if the telomerase activity detected affected the maintenance of 
telomere during long term culture. All cell populations were found to be 
positive for markers CD90, CD105 and CD166, and with the exception of 
three cell populations negative for CD34 and CD45, negating the presence of 
fibrocytic or haematopoietic cells within these cell populations. All populations 
also exhibited active telomerase within cell lysates, suggesting these cells 
are phenotypically distinct from MSCs and characteristically similar to 
embryonic stem cells. The presence of telomerase did not appear to prevent 
the erosion of telomeres in the different cell populations; however a more 
accurate method of telomere length analysis, such as STELA, may highlight 
smaller changes in telomere length with more accuracy that this technique 
could provide. All the data suggests that not only the clonally selected cell 
populations, but the heterogeneous cell populations contain stem cells which 
are capable of self-renewal and as previously shown in chapter 3 can exceed 
the population doublings observed in MSCs. To further elucidate the 
therapeutic potential of these isolated cell populations, it is crucial that the 
multi-lineage potential of these cells is fully investigated to determine how 
effectively the different cell populations form tissues in vitro. 
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CHAPTER 5 
Investigating the chondrogenic, 
osteogenic and adipogenic differentiation 
potential of isolated oral mucosal cell 
populations  
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5.1 Introduction 
As mentioned in previous Chapters, adult stem cells have been isolated from 
multiple sites in the body, with the most characterised site being the bone 
which were the first to be identified (Yoo et al., 2005, Wagner et al., 2005, 
Quirici et al., 2002, Oliveira et al., 2009, Mareschi et al., 2006, Mareddy et al., 
2007, Ishii et al., 2005, Friedenstein et al., 1970).  Adult stem cells have been 
successfully isolated from a number of other tissues including synovial fluid, 
articular cartilage and skin (Chunmeng et al., 2004, Fernandes et al., 2004, 
Toma et al., 2001, Toma et al., 2005, Webb et al., 2004, Alsalameh et al., 
2004, Dowthwaite et al., 2004, Fickert et al., 2004, Hiraoka et al., 2006, 
Williams et al., 2010). With the focus of this project being the lamina propria 
of the oral mucosa, a number of other oral tissues have demonstrated the 
presence of a stem cell population including the oral mucosa epithelium, 
dental papilla and periodontal ligament (Gay et al., 2007, Ivanovski et al., 
2006, Nagatomo et al., 2006, Techawattanawisal et al., 2007, Tomokiyo et 
al., 2008, Trubiani et al., 2010, Wada et al., 2009, Ikeda et al., 2006, Calenic 
et al., 2010, Izumi et al., 2007, Nakamura et al., 2007).  
The characterisation of stem cell populations requires the elucidation of 
differentiation capacity of those cells along a number of potential lineages. 
Stem cells may be multipotent, restricted to differentiate only into the 
lineages of the tissue from which they are isolated such as cortex stem cells 
or haematopoietic stem cells  (Wright et al., 2006, Izumi et al., 2007), or 
totipotent, able to develop into any lineage such as in embryonic stem cells 
(Keller, 1995, Thomson et al., 1998, Heins et al., 2004). 
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The lineage potential of BMSCs is well characterised with differentiation 
along chondrogenic, adipogenic and osteogenic differentiation observed in 
these cells (Romanov et al., 2005, Kolf et al., 2007).(Kotobuki et al., 2008, in 
't Anker et al., 2003). These differentiation characteristics have also been 
documented in the stem cell populations isolated from oral tissues including 
the periodontal ligament, dental pulp and oral mucosa (Gay et al., 2007, 
Nagatomo et al., 2006, Davies et al., 2010, Marynka-Kalmani et al., 2010, 
Gronthos et al., 2002, Otaki et al., 2007a). Clonal expansion can affect the 
differentiation potential of the cells as documented by the increased 
osteogenic potential of osteoblast like cells after selection of cells exhibiting 
high alkaline phosphatise activity (Kotobuki et al., 2004). 
The aim of this chapter was to determine the potential of the isolated cell 
populations to differentiate along adipogenic, osteogenic, and chondrogenic 
lineages, to determine if this potential is similar to the well characterised adult 
stem cell populations. As well as determining the differentiation potential of 
the isolated populations, the comparisons between cell populations to 
determine if clonal selection increased the differentiation potential or if using 
a heterogeneous cell population from the oral mucosa would be just as 
successful in a therapeutic setting for tissue engineering purposes. 
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5.2 Results 
 
5.2.1 Adipogenic Differentiation 
 
5.2.1.1 Quantitative PCR detection of Adipogenic mRNA from patient 
XXVIII cell populations 
To determine the adipogenic potential of cell cultures mRNA was isolated 
from adipogenic cultures induced (A = adipogenic induced)) for 7, 14, 21 and 
28 days, with non induced cultures used as controls (AC). The expression of 
three markers Lipoprotein Lipase (LPL), PPARγ and C/EBP-α, was quantified 
and normalised to the expression of the housekeeper gene β-actin. Due to 
time limitations only patient XXVIII samples were analysed for quantitative 
expression of these markers - 2 clones (3 XXVIII and 9 XXVIII) along with the 
corresponding patient LO and NA populations. Data was analysed for 
statistical significance using one-way ANOVA with a bonferroni post-test 
where p<0.05. 
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5.2.1.1.1 Peroxisome Proliferator Activated Receptor-gamma (PPARγ) 
expression 
Fig 5.1 demonstrates the PPARγ expression of patient XXVIII cell 
populations over a 28 day differentiation study. Expression of PPARγ in 
Clone 3 XXVIII demonstrated a significant increase at day 14 (p<0.001), 
before reducing significantly at day 21 and remaining at a low level until day 
28 (p<0.001, Fig 5.1A). Whilst at 14 days the control expressed significantly 
lower levels of PPARγ than adipogenic cultures, at all other timepoints the 
difference between adipogenic and control cultures demonstrated no 
difference (p>0.05). Similarly 9 XXVIII saw a significant increase at 14 days 
(p<0.001), before a significant reduction in expression by day 21, at which 
level the adipogenic cultures remained at day 28 (Fig 5.1B). As with Clone 3 
XXVIII, the day 14 control expression remained significantly lower (p<0.001), 
after which time the difference between control and adipogenic cultures was 
no longer significant (p>0.05). In LO XXVIII cultures, PPARγ expression 
remained stable up to 21 days without significant changes in expression 
before decreasing at day 28 (p<0.001, Fig 5.1C). For LO cultures all control 
cultures demonstrated significantly lower levels of expression compared to 
adipogenic cultures (p<0.001). NA XXVIII cultures saw expression increase 
at day 14 (p<0.001), remain stable at day 21 before expression deceased 
significantly at day 28 (p<0.001). Expression in control cultures remained 
significantly lower up to day 21 (p<0.001), however at day 28 no significant 
difference between control cultures or adipogenic cultures was observed (Fig 
5.1D). Comparisons between cell populations at each time point determined 
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that LO and NA populations had higher levels of PPARγ expression at day 7, 
compared to Clone 3 XXVIII and Clone 9 XXVIII (all p<0.001).By day 14 the 
differences had reversed with 9 XXVIII demonstrating higher levels of 
expression than LO XXVIII (p<0.001), with Clone 3 XXVIII and NA XXVIII 
exhibiting a similar level of expression to Clone 9 XXVII. At day 21, PPARγ 
expression within Clone 3 XXVIII cultures is significantly lower than all other 
cultures (p<0.001), with no difference in expression detected between the 
LO, NA and Clone 9 XXVIII cultures (p>0.05). At the final time point (day 28), 
the expression in LO XXVIII has decreased to a level comparable to Clone 3 
XXVIII, whilst the only population expressing significant levels of PPARγ in 
relation to the other cell populations is Clone 9 XXVIII.  
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5.2.1.1.2 CCAAT/Enhanced Binder Protein-alpha (C/EBPα) expression 
Expression of C/EBPα mRNA was low by day 7, increasing significantly at 
day 14 (p<0.001) before immediately decreasing back to low levels at day 21 
(p<0.001), where expression remained until day 28 (Fig 5.2A). Whilst 
expression in control cultures at day 14 was significantly lower than the 
adipogenic cultures (p<0.001), difference in adipogenic and control C/EBPα 
expression at all other timepoints were not significant (p>0.05). Clone 9 
XXVIII also demonstrated low levels of expression at day 7, before a 
significant increase in expression at day 14 (p<0.01, Fig 5.2B). Expression 
did not change significantly from day 14 onwards. Differences between 
expression in control cultures and adipogenic cultures were not significantly 
different at day 7 or day 21 (p>0.05), but expression was significantly higher 
in adipogenic cultures when compared to controls at day 14 (p<0.05) and day 
28 (p<0.001) respectively. LO XXVIII demonstrated low levels of expression 
until day 21, when a significant increase in expression was detected 
(p<0.001). This increase continued until day 28 (p<0.001, Fig 5.2C). Whilst 
differences between adipogenic cultures at day 7 and day 14 were not 
significant (p>0.05), the expression of C/EBPα in adipogenic cultures was 
significantly higher at day 21 (p<0.001) and day 28 (p<0.001). NA XXVIII 
cultures demonstrated a similar pattern of expression to LO XXVII, with no 
significant increase observed until day 21 (p<0.001, Fig 5.2D), after which 
time expression remained at a high level. As with LO XXVIII, adipogenic 
culture expression was significantly higher than controls at day 21 (p<0.0010 
and day 28 (p<0.001), however no differences between adipogenic or control 
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C/EBPα expression were observed at day 7 or day 14 (Fig 5.2). 
Comparisons between cell populations demonstrated that at day 7, LO 
XXVIII expressed the highest levels of C/EBPα compared to NA (p<0.05), 
Clone 3 XXVIII (p<0.001) and 9 XXVIII (p<0.001). The levels of expression of 
the other three cell populations were not significantly different. By day 14, 
Clone 3 XXVII has significantly higher levels of expression than LO (p<0.01) 
and NA (p<0.001) and Clone 9 XXVIII (p<0.05) populations. Clone 9 XXVIII 
however expresses lower levels of C/EBPα than LO (p<0.05) and NA 
populations (p<0.05) at day 14. By day 21, LO XXVIII expresses higher 
levels of C/EBPα expression when compared to NA (p<0.0010. Clone 9 
(p<0.001) and Clone 3 (p<0.001). NA XXVIII expression is significantly higher 
than Clone 3 XXVIII (p<0.05) at day 21. Finally at day 28 expression of 
C/EBPα is highest in LO XXVIII when compared to Clone 3 (p<0.001), Clone 
9 (p<0.001) and NA XXVIII (p<0.001). Expression in 9 XXVIII is significantly 
higher than Clone 3 (p<0.001) and NA XXVIII (p<0.001) populations at day 
28. 
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5.2.1.1.3 Lipoprotein Lipase (LPL) expression 
Expression of LPL within Clone 3 XXVII demonstrated no significant 
difference in LPL expression at all timepoints, in either adipogenic or control 
cultures (Fig 5.3A). The same result was observed in Clone 9 XXVIII (Fig 
5.3B). LO XXVIII cultures demonstrated no significant change in expression 
from day 7 to day 14. At day 21 a significant increase in expression was 
observed (p<0.05), and expression remained at this level at day 28 (Fig 
5.3C). Adipogenic cultures expressed significantly higher levels of LPL 
expression compared to controls at day 7 (p<0.01), day 21 (p<0.01) and day 
28 (p<0.001). In the NA cultures, expression of LPL increases significantly at 
day 21 (p<0.01) and remains at this level at day 28 (Fig 5.3D). Levels of 
expression in adipogenic and control cultures are not statistically different 
(p>0.05) at any timepoint in the NA XXVIII cultures. Comparisons of cell 
populations at each timepoint demonstrated that LO XXVIII expressed higher 
levels of LPL at day 7 than Clone 3, Clone 9 and NA populations (p<0.001). 
NA XXVIII also expresses higher levels of LPL than Clone 3 (p<0.001) and 
Clone 9 (p<0.01) at day 7. At day 14, there is no significant difference in 
expression in any cell populations (p>0.05). At both day 21 and day 28, 
Clone 9 expresses higher levels of LPL than Clone 3 (p<0.05), LO XXVIII 
expresses higher levels of LPL when compared to Clone 3 at day 21 and day 
28 (p<0.01 and p<0.001, respectively). 
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5.2.1.2 Oil Red-O Staining of Adipogenic Cultures 
To determine the effectiveness of adipogenic differentiation (i.e. would the 
attempts to drive cell populations down an adipogenic lineage prove 
successful as evidenced through the production of lipid deposits), cells 
cultured for 28 days in adipogenic induction media or control media were 
fixed and stained with Oil Red-O, which allows for the visualisation of fat 
droplets via bright field microscopy. As a control, 3T3-L1 cells were also 
incubated for 28 days in adipogenic media for a positive Oil Red-O staining. 
In patient XVII all cell populations demonstrated the presence of lipid droplets 
after 28 days adipogenic induction, with the most intense staining observed 
in 7 XVII (Fig 5.4). In the LO and NA populations, staining was widespread. 
Clone 6 XVII however showed a very low level of Oil Red-O staining. 
Interestingly in the control cultures, LO XVII also demonstrated positive 
staining for lipid droplets; however this was not as distinct or widespread as 
the staining observed in the adipogenic cultures. However, it was notable that 
all of the cell populations demonstrated dramatically lower level of staining 
when compared to the 3T3-L1 positive control. 
Patient XXVIII demonstrated more concentrated staining compared to patient 
XVII, with no staining present in controls of 3 XXVIII and 9 XXVIII and NA 
XXVIII (Fig 5.5). As already observed in patient XVII, the control LO 
population demonstrated some limited lipid deposition. Clone 3 XXVIII 
demonstrated quite extensive lipid deposition, although this was not as 
extensive as LO XXVIII. Clone 9 XXVIII showed minimal staining with Oil 
Red-O, and NA XXVIII also exhibited a minimal level of staining. 
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5.2.2 Chondrogenic Differentiation 
 
5.2.2.1 Histological Analysis of Chondrogenic Cultures 
After induction of chondrogenic differentiation for 28 days in a pellet culture 
system as described (Chapter 2.6.1), pellets were kindly paraffin embedded 
and 10μm sections cut on a microtome by School of Dentistry Pathology 
MLSO Kath Allsop attached.  Sections were staining using Haemotoxylin and 
Eosin (H&E) staining, and for more specific collagen staining using Van 
Gieson‟s stain.  It was notable that after 28 days in culture only 
chondrogenic-induced pellets remained intact with the controls disintegrating 
(therefore there was no data for control pellets). 
  
5.2.2.1.1 Haemotoxylin and Eosin staining 
The result of H&E staining of the chondropellets for patient XVII 
demonstrated that all cell nuclei are distributed throughout the pellet (Fig 
5.7). The general structure of the pellets appeared more compact in the LO 
and NA pellets with fewer breakages and voids within the pellet than Clones 
3 and 9 XXVIII, which contained many voids around the perimeter of the cell 
pellets. These may be artifacts from sectioning which however, may in turn 
suggest an underlying weakness in such chondropellets formulated form the 
clonal cells. 
The sections for patient XXVIII exhibit similar characteristics to those 
observed for patient XVII, with the exception of Clone 9 XXVIII. The sections 
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of 9 XXVIII were not able to remain intact during processing and sectioning 
however, the remainder of the section was able to demonstrate similar 
staining to that observed within the other cell populations. Clone 3 XXVIII 
demonstrated similar morphology to the clones from patient XVII with voids 
within the sections however, in this instance spread throughout the section 
not just at the periphery. As observed in patient XVII, the LO and NA section 
of patient XXVIII exhibit a more compacted morphology with fewer voids 
present throughout the sections. The nuclei were again distributed 
throughout the cell pellets, again suggesting that the entire pellet remained 
viable for the entire 28 day differentiation culture. 
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5.2.2.1.2 Van Gieson’s 
In addition to the general histology staining, Van Gieson‟s staining was used 
for investigating the presence of collagen within the chondrogenic pellets; an 
indication of successful differentiation along the chondrogenic lineage. 
Collagen will stain red, whilst cellular cytoplasm and muscle stains 
yellow/brown. Sections from patient XVII demonstrated staining for collagen 
throughout the sections, with the exception of 7 XVII which exhibited an 
unusual pattern of staining. The presence of collagen with 6 XVII was 
prevalent throughout the pellet, although staining was not as strong as 
observed within the pellets from LO and NA XVII (Fig 5.9), where the most 
distinct staining was observed at the periphery of the pellet sections. Patient 
XXVIII samples also contained collagen, and this was concentrated at the 
periphery of NA XXVIII sections, but more widespread in Clone 3, 9 and LO 
XXVIII sections. Sections from 9 XXVIII were again unable to remain intact 
during the sectioning process; however, the partial sections still 
demonstrated the presence of collagen through red staining. 
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5.2.3 Immunhistochemical Analysis of Chondrogenic Cultures 
To determine if the results of the general histology staining represented true 
chondrogenic differentiation, cryopreserved sections were investigated for 
the presence of aggrecan, a proteoglycan which together with type II 
collagen comprises one of the main structural components of (Bayliss et al., 
2000). All staining was conducted using the 6B4 aggrecan antibody kindly 
donated by Prof. Bruce Caterson School of Biosciences, Cardiff University. 
Primary negative and secondary negative controls were used to ensure non-
specific binding was not responsible for the staining. 
Clone 6 XVII demonstrated positive staining with aggrecan (Fig 5.11A) and 
corresponding DAPI staining indicates this is most prominent at the periphery 
of the pellet sections. Closer microscopic examination of the pellet confirms 
that the expression of aggrecan is highest at the edge of the section (Fig 
5.11D). Clone 7 XVII demonstrated faint aggrecan staining compared to 6 
XVII, and lacked the peripheral staining mentioned in 6 XVII pellets (Fig 
5.12). LO XXVIII pellets demonstrated very strong staining at the periphery of 
the sections, and the same pattern of expression was also observed in the 
NA XXVIII population, with a strong band of staining around the section edge 
(Fig 5.13, Fig 5.14). In all sections, both controls remained negative for any 
staining. 
Clone 3 XXVIII stained for aggrecan, located primarily at the periphery of the 
section. However some unbound secondary antibody remained bound after 
washes and can be observed as bright spots located all over the section (Fig 
5.15A). Clone 9 XXVIII exhibited widespread staining for aggrecan 
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throughout the section without extensive staining at the periphery as 
observed in 3 XXVIII (Fig 5.16A). As observed with the LO and NA 
populations from patient XVII, staining for aggrecan was most prominent at 
the edge of the sections from LO and NA XXVIII but staining was present 
throughout the pellet sections. 
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FIG 5.10 
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FIG 5.11 
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5.2.3 Osteogenic Differentiation 
5.3.1 Alizarin Red Staining of Osteogenic Cultures 
To determine if the isolated cell populations were capable of osteogenic 
differentiation in vitro under induction conditions, cells were cultured for 28 
days and stained with alizarin red, a histological stain which binds to calcium 
deposits and produces a red colour. In patient XVII all cell populations were 
capable of osteogenic differentiation as observed by strong staining of 
calcium deposits, with no apparent differences in intensity of staining 
between cell populations (Fig 5.18). Similarly all populations of patient XXVIII 
are capable of osteogenic differentiation however; both NA XXVIII and 9 
XXVIII demonstrate lower levels of staining, with small localised deposits 
compared to the more widespread staining observed in 3 XXVIII and LO 
XXVIII (Fig 5.19). In both patients, control populations appear to have no 
calcium deposits, suggesting that the effects of the osteogenic media are 
responsible for the presence of staining in osteogenic cultures. 
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5.3 Discussion 
The aims of this chapter were to determine the differentiation potential of the 
isolated oral mucosal cell populations and to determine if their lineage 
potential is similar to that observed within other adult stem cell populations. 
To this end the potential toward osteogenic, adipogenic and chondrogenic 
differentiation were probed.  
Adipogenic differentiation was determined through mRNA expression of 
lineage specific markers CCAAT/enhancer binding protein-alpha (C/EBPα), 
peroxisome proliferator activated receptor (PPARγ) and Lipoprotein lipase 
(LPL) using QRT-PCR. C/EBPα and PPARγ are both early stage indicators 
of Adipogenesis whilst LPL is classed as a late stage marker of adipogenic 
differentiation (Morrison and Farmer, 2000).. In terms of PPARγ expression, 
LO and NA populations appear to respond to adipogenic induction earlier 
than Clonal populations, with higher levels of expression at day 7, but by day 
14 the Clonal populations demonstrated a stronger response with higher 
expression. C/EBPα expression was delayed in LO and NA populations 
compared to the Clones which increased expression at day 14 compared to 
day 21/28 seen in the LO/NA XXVIII populations. Expression of LPL within 
the LO/NA populations was higher than the level recorded in the other cell 
populations at day 7, whilst at day 14 there was no significant difference in 
expression. Clone 3 did not appear to express LPL at levels near those 
observed in the cell populations, suggesting that whilst the early markers of 
adipogenesis are upregulated, the differentiation of these cells requires 
additional stimulation for full adipogenesis. The variation in LPL expression 
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suggests that this data is not conclusive, as levels of LPL appear to increase 
in control cultures at levels comparable to the adipogenic induction cultures. 
Further experiments are required to determine the true role of LPL within the 
cell populations during adipogenic differentiation.  Confirmation of 
differentiation Oil Red-O staining to confirm the presence of intracellular lipid 
droplets,  suggests that whilst temporal differences are apparent in the 
different cell populations in terms of the expression of the early markers of 
adipogenesis, this has little bearing on the level of lipid deposition. In both 
patients LO populations appear to show the most widespread lipid staining, 
suggesting that some aspect of this cell population precludes it to undergo 
adipogenic differentiation. An interesting result was the presence of lipid 
staining within the control cultures of LO for both patients. This may be an 
artefact of culturing the cells at confluence for 28 days, which may induce a, 
adipogenic-like state. The inclusion of a day 0 timepoint or from cells which 
were nearing senescence may highlight genetic changes that may be distinct 
from adipogenesis, but still lead to lipid staining. It may suggest a level of 
contamination of the heterogeneous cell population during the isolation 
process with adipocytes from the lamina propria, and could explain why the 
other clonally selected and NA populations did not appear to display lipid 
accumulation in the control cultures. This phenomenon has been observed 
previously in bronchial lung fibroblasts which exhibited a mesenchymal stem 
cell phenotype, so is perhaps not unsurprising (Sabatini et al., 2005). In other 
tissues, spontaneous differentiation has been documented, adipose stromal 
cells have been reported to differentiate into cardiomyocytes (Planat-Benard 
et al., 2004). Utlimately the differentiation along the adipogenic lineage was 
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achieved in all cell populations, with the lipid staining suggesting that the 
heterogeneous LO cell population was more capable of adipogenic 
differentiation in vitro due to higher levels of observable lipid accumulation 
however, without a validated method of quantification then conclusions 
cannot be drawn at this time. In the future use of a technique incorporating 
the use of DAPI counterstaining for quantification of lipid production in 
relation to cell number may provide a better level of differentiation (Gorjup et 
al., 2009).  This data contrasts with the use of buccal mucosa fibroblasts as a 
negative control for dental pulp stem cell experiments, where it was reported 
that buccal mucosal fibroblasts, which are effectively the LO population in 
these experiments, were unable to undergo adipogenic differentiation 
(Lindroos et al., 2008). The ability of these cells to successfully undergo 
differentiation along the adipogenic lineage conforms to the data from other 
adult stem cell populations both BMSC and cell populations derived from oral 
tissues including the lamina propria of the oral mucosa (Seo et al., 2004, 
Pittenger et al., 1999, Romanov et al., 2005, Sabatini et al., 2005, Schilling et 
al., 2007, Davies et al., 2010, Marynka-Kalmani et al., 2010). 
Chondrogenic differentiation was successful in all cell populations, with the 
expression of aggrecan confirmed by immunohistochemistry and the 
presence of collagen detected by Van Gieson‟s staining. The pellet culture 
system was chosen for chondrogenic differentiation as it provides a three-
dimensional culture system exposed to mechanical stresses through regular 
centrifugation simulating load bearing as it would be experienced in cartilage 
(Yang et al., 2004). Differences were observed in structural integrity of the 
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pellets, with the LO and NA populations in both patients appearing to 
remaining intact during sectioning, suggesting the underlying tissue produced 
during differentiation was more developed that that observed in the clonally 
derived cell populations. The failure of control pellets to survive the culture 
period suggests that cells from the oral mucosa are not able to differentiate 
spontaneously just from the pellet culture condition as reported in bovine 
mesenchymal stem cells (Bosnakovski et al., 2004, Bosnakovski et al., 
2006), and that the presence of induction factors is crucial. To draw 
comparisons of the levels of differentiation beyond the structural differences 
observed in the histology staining would require additional analysis. Attempts 
were made to isolate RNA from chondrogenic pellets for RT-PCR analysis 
however; these were unsuccessful due to the low concentrations of RNA 
isolated. If this had been successful, temporal changes in chondrogenic gene 
expression may have been detected which would allow differences between 
cell populations to be observed. Chondrogenic differentiation has been 
demonstrated in adult stem cell populations from multiple sites including 
BMSC and oral tissues (Davies et al., 2010, Marynka-Kalmani et al., 2010, 
Bernstein et al., 2009, Bosnakovski et al., 2004, Lin et al., 2005, Majumdar et 
al., 2000, Yanada et al., 2006, Yoo et al., 1998, Hiraoka et al., 2006). 
Osteogenic differentiation was confirmed using Alizarin red staining for the 
presence of calcium deposits after 28 days culture in the presence of 
osteogenic induction medium. The control cultures did not exhibit any 
staining. In patient XVII the level of calcium deposition was comparable in all 
cell populations, with large areas of staining observed.  In patient XXVIII the 
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NA population appeared to show a reduced capacity for osteogenic 
differentiation. The same was apparent from the levels of staining within 9 
XXVIII cultures. Further characterisation of the differentiation is needed, in 
terms of the expression of bone specific differentiation markers during 
differentiation. RNA was extracted from osteogenic cultures to determine 
whether the cell populations did express the common markers of osteogenic 
differentiation however, technical issues and time constraints prevented 
further analysis. In the future this is a key analysis for the better 
understanding of any differences which may occur in differentiation between 
the cell populations. Successful differentiation along the osteogenic lineage, 
as with the chondrogenic and adipogenic lineages, supports the findings in 
other stem cell populations from BMSCs to dental pulp stem cells, and 
supports the work carried out within the Wound Biology Group and elsewhere 
into lamina propria stem cell populations (Aslan et al., 2006, Bruder et al., 
1997, Gabbay et al., 2006, Ikeda et al., 2006, Im et al., 2005, Jahoda et al., 
2003, Kotobuki et al., 2005, Kotobuki et al., 2008, Davies et al., 2010, 
Marynka-Kalmani et al., 2010). 
The aims of this chapter were to investigate the differentiation potential of the 
isolated cell populations and determine whether the differentiation capacity of 
these cell populations was affected by the stage of the differential adhesion 
assay from which the population derived. All cell populations successfully 
demonstrated the ability to differentiate along the common mesenchymal 
lineages, which supports the findings in other stem cell populations from 
adult tissues populations (Aslan et al., 2006, Bruder et al., 1997, Gabbay et 
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al., 2006, Ikeda et al., 2006, Im et al., 2005, Jahoda et al., 2003, Kotobuki et 
al., 2005, Kotobuki et al., 2008, Davies et al., 2010, Marynka-Kalmani et al., 
2010, Bernstein et al., 2009, Bosnakovski et al., 2004, Lin et al., 2005, 
Majumdar et al., 2000, Yanada et al., 2006, Yoo et al., 1998, Hiraoka et al., 
2006, Seo et al., 2004, Pittenger et al., 1999, Romanov et al., 2005, Schilling 
et al., 2007, Sabatini et al., 2005). Interestingly, the heterogeneous LO and 
NA populations appear to demonstrate the ability to differentiate as well as 
the clonally derived cell populations, and whilst there appear to be temporal 
differences in expression of markers at mRNA level, as observed in the 
adipogenic differentiation studies, the end point of successful differentiation is 
still achieved. 
Cells of the lamina propria are developmentally derived from the neural crest 
(Winning and Townsend, 2000, Davies et al., 2010). Neural crest stem cells 
have been identified in a number of tissues, including oral tissues such as the 
adult palate (Widera et al., 2009). Work within the wound biology group has 
demonstrated the ability of clonally derived lamina propria stem cells to form 
neural lineages in vitro (Davies et al., 2010), suggesting that the lineage 
potential of these cells is greater than the potential reported in mesenchymal 
stem cells and would therefore make lamina propria progenitor cells a useful 
resource for tissue engineering and stem cell therapies. The work presented 
in this Chapter suggests that clonally selecting cells using their adherence 
properties may not be as important as first hypothesised, as the 
heterogeneous LO population, and even the NA population which should be 
depleted of stem/progenitor cells based on the principle of the differential 
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adhesion assay are capable of mesenchymal differentiation in vitro. 
Investigation into whether the neural differentiation observed in the clonal 
populations could be replicated in the LO and NA populations would be a 
useful addition to the research already conducted on lamina propria stem 
cells. 
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CHAPTER 6 
General Discussion 
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6.1 General Discussion 
In this thesis, the growth kinetics, telomerase activity and differentiation 
potential of multiple cell populations isolated from the lamina propria of the 
oral mucosa were described. The oral mucosa is well documented for 
superior healing compared to the skin, with increased replicative potential 
when compared to skin fibroblasts in vitro (Enoch et al., 2010, Enoch et al., 
2009, Stephens et al., 1996, Stephens et al., 2001a, Lee and Eun, 1999). It 
has been hypothesised that these characteristics are due to a 
progenitor/stem cell population within the lamina propria which contribute to 
this preferential healing response (Stephens and Genever, 2007). Recent 
discoveries of stem cell populations within other craniofacial tissues have 
given more weight to the argument for the presence of a stem cell population 
within the oral mucosa (Calenic et al., 2010, Gagari et al., 2006, Huang et al., 
2009, Izumi et al., 2007, Nakamura et al., 2007). Ultimately this hypothesis 
has been demonstrated by work conducted within the Wound Biology Group, 
and another research group based in Israel into stem cells within the buccal 
and gingival mucosa (Davies et al., 2010, Marynka-Kalmani et al., 2010, 
Zhang et al., 2010, Zhang et al., 2009). In order to further explore the 
characteristics of these cells, clonally derived cell populations derived from 
the buccal mucosa, along with those cells unable to adhere during the 
adhesion assay and heterogeneous cell populations representing the whole 
lamina propria were grown until senescence and the presence of stem cell 
associated markers and characteristics investigated. Therefore the first aim 
of this thesis was to successfully isolate cell populations using the differential 
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adhesion assay, and investigate their growth characteristics in regard to the 
wider field of adult stem cell biology. 
 
In Chapter 3 the colony forming efficiency, growth potential and 
morphological changes with in vitro ageing were studied to determine if the 
clonally derived cell populations differed in vitro to the other cell populations 
derived from the lamina propria during the differential adhesion assay. This 
assay has been used for the isolation of stem cells within the epidermis of the 
skin, and articular cartilage, exploiting the increased expression of α5b1 
integrin on the surface of progenitor/stem cells to ensure those cells are able 
to adhere rapidly and  (Dowthwaite et al., 2004, Williams et al., 2010, Jones, 
1996, Jones and Watt, 1993). As well as demonstrating an increased 
adherence to fibronectin, there was evidence of an increased colony forming 
efficiency within those rapidly adhering cells as determined by the ability to 
form colonies from a single adherent cell, and this effect was seen in all 
patients used in this assay. In this respect these cells share similarities with 
mesenchymal stem cells, which have long been isolated using the colony 
forming unit fibroblast (CFU-F) assay, another method of calculating the 
ability to derive from a single cell (Castro-Malaspina et al., 1984, Castro-
Malaspina et al., 1982, Castro-Malaspina et al., 1980, Deans and Moseley, 
2000). After isolation of clonally expanded cell populations, along with the LO 
and NA populations previously described, cells were cultured through to 
cellular senescence, and at each passage cells were counted and the cell 
number along with the seeded cell number were used to calculate total 
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population doublings. Over the lifetime of the cell populations, an average 
growth rate was calculated to determine if within the context of total average 
growth rate, there were any differences within the different cell populations. 
The results demonstrated the ability of all cell populations to exceed 50 
population doublings in vitro with the exception of one clonal cell population 
(10XVII). This growth potential is comparable, if not greater than the 
replicative potential observed in MSCs isolated from bone marrow or cord 
blood (Bieback et al., 2004, Colter et al., 2000, Banfi et al., 2000, Baxter et 
al., 2004, Bruder et al., 1997). With respect to adult stem cell populations 
derived from other tissues, stem cells isolated from the dental pulp have 
been reported to in excess of 20-40 population doublings (Gronthos et al., 
2002, Suchanek et al., 2009, Suchanek et al., 2007). Articular cartilage 
progenitor cells have been reported reaching 60 population doublings 
(Dowthwaite et al., 2004, Williams et al., 2010). Other groups have reported 
findings in terms of population doubling time (Widera et al., 2009). This does 
not however provide any information about the proliferative capacity of these 
cell populations however and ultimately cannot be used in the same way to 
determine the replicative potential of isolated stem cell populations. The 
results found with the lamina propria derived cell populations suggest that, 
irrespective of clonal selection of cells based on adherence characteristics, 
these cells are capable of a vastly increased replicative potential, as already 
characterised from work on oral fibroblasts (Stephens et al., 1996, Stephens 
et al., 2001a, Enoch et al., 2010, Enoch et al., 2009). The final analysis of 
Chapter 3 was to determine any morphological changes associated with in 
vitro ageing in the isolated cell populations. The age related changes 
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considered markers of senescence, observed in both MSC and fibroblast 
populations include an increase in cell size with an associated change in cell 
morphology (Baxter et al., 2004, Banfi et al., 2000, Bruder et al., 1997, 
Hayflick, 1965). In this manner, the isolated cell populations demonstrated 
the same age related changes, with an increase in cell size observed in all 
cell populations with the exception of clone 10 XVII, which underwent early 
senescence. Along with change in cell size, a visible flattening of cells and an 
increase in the number of cellular processes occurred. The differences in cell 
size between cell populations varied between patients, and with no distinct 
difference between clonal populations and LO populations. The lack of a third 
patient for analysis excludes the presentation of a common trend within the 
cell populations and is crucial for any future work into these cell populations. 
Overall the analysis presented in Chapter 3 indicates that differential 
adhesion does allow for the selection of a highly clonogenic cell population 
which exhibits distinct growth kinetics when compared to whole lamina 
propria (LO) digests, and that those cells which do not adhere during the 
assay (NA) behave in a similar manner to those LO cells. Interestingly the 
cell population with the highest cumulative population doublings remains the 
LO population, suggesting that this heterogeneous population allows for the 
maintenance of the resident stem cell population over time in culture. The 
clonal populations undergo many population doublings before senescence, 
but the heterogeneous cell population may enhance the replicative potential 
of the resident stem cell population, remaining quiescent and only dividing 
when those terminally differentiated cells become senescent and effectively 
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„drop out‟ of the proliferating population. This may explain the higher number 
of population doublings achieved before senescence was observed within the 
LO populations of both patients. Finally changes in cell morphology appear to 
occur as expected from both MSC and fibroblast characterisation as 
mentioned previously.  
 
The second aim of this thesis was the characterisation of the isolated cell 
populations with regard to the presence of stem cell associated markers. 
These included the presence of stem cell surface markers as identified from 
the literature; CD90, CD105 and CD166. The inclusion within this panel of 
markers of CD34 and CD45 allowed for the confirmation that these cells were 
not of fibrocyte or haematopoietic origin (Pasquinelli et al., 2007, Nagatomo 
et al., 2006, Song et al., 2005, Diaz-Romero et al., 2005). All cell populations 
proved to be positive for all three markers as observed in stem cell 
populations isolated from a number of tissues including bone marrow, 
periodontal ligament, dental pulp, cartilage, synovial fluid and adipose tissue 
(Trubiani et al., 2010, Wada et al., 2009, Tomokiyo et al., 2008, Gay et al., 
2007, Nagatomo et al., 2006, Hiraoka et al., 2006, Fickert et al., 2004, 
Dowthwaite et al., 2004, Alsalameh et al., 2004, Zannettino et al., 2008, 
Ikeda et al., 2006, Morito et al., 2008). It also confirms the findings already 
observed in the buccal and gingival mucosa (Davies et al., 2010, Marynka-
Kalmani et al., 2010). Slight levels of staining were present in three of the cell 
populations analysed by flow cytometry for CD34 and CD45, but this was 
attributed to non-specific binding due to out of date antibodies and not due to 
196 
 
the phenotype of the cell population in question. The next analysis was to 
determine the telomerase potential of isolated cell populations to understand 
the replicative potential observed within the cell populations, and to 
determine if they are superior to MSCs by the presence of active telomerase, 
as this has yet to be identified with MSCs (Zimmermann et al., 2003, Fehrer 
and Lepperdinger, 2005). Telomerase has been identified in haematopoietic 
cells and neural precursor cells and in chondrogenic progenitors from 
articular cartilage (Chiu et al., 1996, Ostenfeld et al., 2000, Williams et al., 
2010). The presence of active telomerase suggests that these isolated cell 
populations are superior to MSCs in confirmation of their superior replicative 
potential, and present a more promising therapeutic choice for tissue repair. 
The stem cells which demonstrate well documented telomerase activity are 
embryonic stem cells (Heins et al., 2004, Thomson et al., 1998). The 
expression of telomerase within the isolated cell populations suggests a 
“younger” phenotype more akin to ESCs than MSC. This correlates with the 
phenotypic analysis of oral mucosal fibroblasts and may contribute to the 
preferential healing in vitro. Interestingly the presence of active telomerase in 
the LO and NA populations suggests that even after differential adhesion, a 
progenitor cell population with telomerase potential and expressing stem cell 
surface markers persist within that NA population.   
The final analysis was to determine the telomere lengths within isolated cell 
populations at early, mid-stage and late time points to observe any age-
related changes in telomere length which may indicate the levels of 
telomerase detected within the samples are responsible for the high 
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replicative potential of these cell populations. The erosion of telomeres has 
been demonstrated to contribute to replicative senescence in somatic cells, 
and telomere shortening has been linked with rapid in vitro ageing of MSCs 
(Baxter et al., 2004, Rubin, 2002, Wagner et al., 2008, Hayflick, 1965). The 
presence of telomerase within the samples did not appear to prevent the 
shortening of telomeres within cell populations, indeed the cells which were 
able to demonstrate longer telomeres at the late time point were the cell 
population which underwent senescence at a much earlier PD, suggesting 
that senescence in these cell populations was not caused by a telomerase-
dependent mechanism. This supports the findings reported in oral fibroblasts, 
that senescence occurs by telomerase independent mechanism. (Enoch et 
al., 2009). 
The overall aim of Chapter 4 was to determine if the cell populations isolated 
demonstrated the characteristics attributed to stem cell populations. 
Investigations of marker expression and telomerase activity demonstrate that 
these cells are superior to BMSCs and other adult stem cell populations, and 
the presence of telomerase would allow for a more plentiful source of stem 
cells for tissue regeneration and repair. The resulting telomerase activity 
reported in the LO/NA population, along with the presence of stem cell 
associated marker suggests that the lamina propria of the oral mucosa could 
be used without clonal selection of progenitor cells within the population, as 
even the fibroblastic NA population exhibits stem cell characteristics. 
The aims of Chapter 5 were to determine if the isolated cell populations, 
already identified as stem cell like by the data of the previous two chapters 
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were able to differentiate along a number of mesenchymal lineages. The 
understanding of the lineage potential of these cells is crucial for tissue 
engineering and repair applications, to determine if they represent a more 
suitable choice of adult stem cell than other, better characterised cells such 
as BMSCs. The lineage potential of BMSCs is well characterised with 
differentiation along chondrogenic, adipogenic and osteogenic differentiation 
observed in these cells (Romanov et al., 2005, Kolf et al., 2007).(Kotobuki et 
al., 2008, in 't Anker et al., 2003). Differentiation potential of stem cell 
populations isolated from the periodontal ligament, dental pulp and oral 
mucosa suggest they would all be useful replacements for BMSC to this end 
(Gay et al., 2007, Nagatomo et al., 2006, Davies et al., 2010, Marynka-
Kalmani et al., 2010, Gronthos et al., 2002, Otaki et al., 2007a). Clonal 
expansion can affect the differentiation potential of the cells (Kotobuki et al., 
2004), and therefore the comparison between cell populations to determine if 
differential adhesion selected for cells with an increased differentiation 
capacity would be important to determine if this isolation method is 
necessary, or if simple heterogeneous cultures are equally capable of 
repairing tissue in vivo. The three “classical” lineages were chosen for this 
thesis, adipogenic, chondrogenic and osteogenic differentiation. Recent 
findings suggested buccal mucosal fibroblasts were incapable of 
differentiation and were included in a paper on the stem cell properties of 
other dental stem cell populations, however in this thesis the successful 
differentiation of all cell populations, including the LO population which was 
comparable to the buccal mucosal fibroblasts along adipogenic, osteogenic 
and chondrogenic lineages (Lindroos et al., 2008) in confirmation of the 
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research already conducted into the differentiation potential of lamina propria 
stem cell populations (Davies et al., 2010, Marynka-Kalmani et al., 2010). 
Adipogenic differentiation was demonstrated through the presence of lineage 
specific mRNA using both quantitative PCR. Differences in expression and 
time of response observed by did not relate to differences in levels of lipid 
accumulation observed in the adipogenic cultures, and the LO populations 
appeared to demonstrate a higher level of differentiation, at least at a 
histological level observed by Oil Red-O staining. Chondrogenic and 
Osteogenic differentiation were confirmed at a histological level through the 
staining of collagen and aggrecan within pellet culture sections and alizarin 
red staining for the presence of calcium respectively. In both lineages the use 
of more quantitative methods of assaying successful differentiation would be 
crucial to a better understanding of the differences between cell populations 
during differentiation, however it would appear that the whole cell population 
is able to undergo differentiation. This may be due to the increase of stem 
cells within the heterogeneous cell populations in culture. It has been 
demonstrated through the rapid intial proliferation during differential adhesion 
that those cells are capable of clonally expanding in vitro. These cells may be 
increasing within the heterogeneous population, and perhaps even within the 
NA populations a small sub population of multipotent stem cells remains 
which is responsible for the observed differentiation capability of these cells. 
Ultimately these in vitro differentiation experiments are not representative of 
the three-dimensional environment for which tissue repair therapies will be 
designed, and therefore more work is required to identify if these cell 
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populations are capable of generating multiple tissues in an in vivo 
environment.   
The overall aim of this thesis was to compare the clonally expanded oral 
mucosa lamina propria stem cells (OMLPSCs) with cell populations isolated 
by different means, in the context of the tissue from which they derive. This 
was to determine if any phenotypic characteristics differentiated them from 
normal cells resident within the tissues. However through comparisons of the 
cell populations for their replicative potential and other stem cell associated 
markers it became apparent that the LO and NA populations, both 
heterogeneous populations derived from the lamina propria, are potentially 
equal to the clonally derived cells in terms of stem cell markers and lineage 
potential. Further investigation into the differentiation mechanisms of those 
lineages investigated in this thesis and indeed of further lineages to probe the 
full lineage potential of these cells is crucial to the success of the lamina 
propria as the superior source of multipotent stem cells. The ease of access 
and minimally invasive procedure involved in the isolation of cells from the 
lamina propria, along with the minimal scarring characteristics of oral tissues, 
make it an exploitable option for tissue engineering and repair. The initial 
hypothesis of this thesis, that the clonally derived cells would exhibit a distinct 
phenotype was found to be incorrect. The presence of stem cell 
characteristics and the capability of differentiation along adipogenic, 
osteogenic and chondrogenic lineages suggest that contrary to the initial 
hypothesis, LO and NA populations appear to be enriched for 
stem/progenitor cell populations, and this is an interesting finding in the wider 
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context of adult stem cell populations, which typically represent a small niche 
within the host tissue. 
 
6.2 Future Work 
The potential of cells isolated from the oral mucosa lamina propria for tissue 
engineering purposes appears promising on the basis of the work contained 
within this thesis and work completed within the Wound Biology Group. 
However with the study of only two patient samples it is problematic to draw 
solid conclusions from the data presented. If continuing this work in future the 
first point to address would be the addition of at least one extra patient to the 
study, preferably a larger number of patients than three to ensure the 
statistical power of any observations and ensure that variation due to patient 
heterogeneity is controlled for within the experimental setup. Analysis of 
telomere lengths was conducted using the TRF assay, which is only a crude 
method of monitoring changes to telomere length. In the future use of the 
STELA technique, to observe telomere erosion at a very high resolution 
would be more informative to elucidate any telomere-dependent changes to 
the different cell populations. The differentiation of the cell populations along 
the chondrogenic, osteogenic and adipogenic differentiation was 
demonstrated, however the ability of Oral Mucosal cell populations compared 
to progenitors from each of these development origins would help determine 
if the Oral Mucosa is the best source of cells for regenerative medicine, and 
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indeed if any differences between cell populations are present in terms of 
differentiation potential.  
If continuing this study, direct comparison of differentiation ability with 
populations such as chondroprogenitors for chondrogenic differentiation 
(Williams et al., 2010), may identify where oral mucosal progenitor cells 
reside within the field of stem cell biology. As well as an extension of the 
differentiation potential already observed within this thesis, in the future it 
would be prudent to investigate other potential lineages which may be 
possible with lamina propria cell populations. Work already conducted has 
demonstrated that adult stem cell populations from other tissues are not 
limited to the adipogenic, chondrogenic and osteogenic lineages. Adipose 
derived stem cells have been demonstrated to be capable of expressing 
neuronal lineage markers when subjected to the correct growth conditions 
(Guilak et al., 2006, Gimble and Guilak, 2003b, Gimble and Guilak, 2003a, 
Safford et al., 2002).  In addition the presence of a neurogenic cell population 
within the dermis of mammalian skin, dental pulp has been demonstrated 
(Toma et al., 2001, Arthur et al., 2008). Work within the Wound Biology 
Group and elsewhere has demonstrated that clonally derived stem cells from 
the lamina propria are also capable of differentiating along the neuronal 
lineage in vitro (Davies et al., 2010, Marynka-Kalmani et al., 2010). Recently, 
the potential for in vitro oogenesis was reported in cells derived from porcine 
skin (Song et al., 2011). A potential avenue of future research would be to 
replicate the neuronal differentiation demonstrated in the clonally derived 
cells, and expand this work to include the LO and NA populations studied in 
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this thesis, to determine if clonal expansion does indeed isolate cells with a 
greater differentiation repertoire.  
Another recent development in stem cell biology was the discovery of 
induced pluripotency of reprogrammed skin fibroblasts – iPS cells (Takahashi 
and Yamanaka, 2006, Takahashi et al., 2007b). This was achieved through 
the introduction of four factors required for embryonic stem cell maintenance 
and self-renewal. These factors are Oct-3/4, Sox-2, Klf-4 and c-Myc, and 
reverts skin fibroblasts back to an embryonic stem cell state, from which point 
it is possible to drive differentiation along any endo-, ecto- or mesodermal 
lineage. Recent advancements have led to the refinement of this method, the 
removal of c-Myc, a potent oncogene, and in the case of neural stem cells, 
which endogenously express three of the four factors, only oct-4 is required 
to induce pluripotency (Wernig et al., 2008, Kim et al., 2009, Kim et al., 
2008). Work within the Wound Biology Group has demonstrated that whole 
oral mucosa lamina propria digests are positive for expression of Oct-3/4, 
Sox2, and Klf-4, suggesting that this cell population is already in a pluripotent 
state without induction, and may be capable of unrestricted differentiation as 
observed in iPS cells. An intriguing avenue of research would be to 
investigate the induction of pluripotency within the oral mucosal cell 
populations, to determine if (a) it is possible to achieve this using the 
introduction of the final required factor via genetic modification, in this case c-
myc and (b) if successful in reprogramming all of the cell population studied 
in this thesis, would any differences in phenotype arise. Additionally, 
investigating if the presence of the iPS markers as reported by Davies et al 
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within the lamina propria can be exploited to alter the phenotype through 
culture conditions alone. A similar technique was employed using 
recombinant proteins in murine fibroblasts, eliminating the need for genetic 
modification (Zhou et al., 2009). 
In terms of future work to be conducted on the basis of the findings presented 
in this thesis, I believe a variety of experiments could be conducted to further 
characterise the different cell populations described, and to determine if the 
Oral Mucosa does represent a good source of stem cells for the purposes of 
regenerative and tissue engineering. 
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Fig 8.1. The Telomeric Repeat Amplification Protocol (TRAP) assay results for clones 5, 12 
and 17 XV and clone 14 XIII using varying amounts of cell lysate. hTERT transfected cells 
were used as a positive control (+ve) and heat inactivated cell lysate was used as a negative 
control (HI) 
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Fig 22. The Telomeric Repeat Amplification Protocol (TRAP) assay results for clones 6 and 
10 XVII, and NA XVII and LO XVII  using varying amounts of cell lysate. hTERT transfected 
cells were used as a positive control (+ve) and heat inactivated cell lysate was used as a 
negative control (HI) 
 
